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INTRODUCTION 
Tuberculosis (TB) has the dubious distinction of being the most persistent scourge of 
humankind. Worldwide statistics are staggering: in 2001, the WHO estimated that 
1.86 billion persons were infected with tuberculosis. Each year, 8.74 million develop 
tuberculosis and nearly 2 million die. This means that someone somewhere contracts 
TB every four seconds and one of them dies every 10 seconds. The global community 
woke up to this disease when, in 1993, the WHO declared TB as a global emergency.1 
In 2008, there were an estimated 9.4 million new cases, equivalent to 139 cases/ 
100,000 population of TB globally. There were an estimated 11.1 million prevalent 
cases of TB in 2008 equivalent to 168 cases per 100,000 population. The South East 
Asia region accounts for 34% of the global TB burden.2 
Though India is the second most populous country in the world, it has more new TB 
cases annually than any other country. In 2008, out of an estimated global annual 
incidence of 9.4 million TB cases, 1.98 million were estimated to have occurred in 
India, of whom 0.87 million were infectious cases, thus catering to a fifth of the 
global burden of TB. On a national scale, the high burden of TB in India is illustrated 
by the estimate that TB accounts for 17.6% of deaths from communicable disease and 
for 3.5% of all causes of mortality. The WHO estimated TB mortality in India was 
276,000 (24/100,000 population) in 2008.2 More than 80% of the burden of 
tuberculosis is due to premature death, as measured in terms of disability-adjusted life 
years (DALYs) lost. 3 
Every day, more than 5,000 people develop TB disease, and nearly 1,000 people die 
of TB, i.e. 2 deaths every 3 minutes. TB is also the leading killer of women, causing 
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more orphans than those produced by all causes of maternal mortality combined. 
Besides the disease burden, TB also causes an enormous socioeconomic burden to 
India. TB primarily affects people in their most productive years with important 
socio-economic consequences for the household when an individual falls sick with 
TB. The disease is even more common among the poorest and marginalized sections 
of the community. Almost 70% of TB patients are aged between the ages of 15 and 54 
years. While two thirds of the cases are male, TB takes a disproportionately larger toll 
among young females, with more than 50% of female cases occurring before 34 years 
of age. In addition there is a devastating social cost – more than 300,000 children are 
forced to leave school because their parents have TB, and more than 100,000 women 
with TB are rejected by their families. The direct and indirect cost of TB to India for 
morbidity alone amounts to an estimated Rs. 12,000 crores ($3 billion) annually (in 
2000). Studies suggest that on an average, 3 to 4 months of work time is lost as a 
result of TB, resulting in an average potential loss of 20-30% of the annual household 
income. This leads to increased debt burden, particularly for the poor and 
marginalized sections of the population. 4 
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 THE EVOLUTION OF TUBERCULOSIS CONTROL IN INDIA 
1.1.1 NATIONAL TUBERCULOSIS CONTROL PROGRAMME (NTP) 
The National Tuberculosis Control Programme (NTP) was launched in 1962. The strategy 
was based on early detection and treatment thereby converting infectious cases to non- 
infectious and preventing non-infectious cases from becoming infectious. 
Diagnosis was made through radiology and sputum microscopy. Free domiciliary 
treatment (Short Course Chemotherapy) was provided through the Primary Health Care 
Services by establishing a District Tuberculosis Centre (DTC) in every district. 
The programme suffered from poor managerial control, inadequate funding, over reliance 
on X-Rays,  non-standard treatment regimens, low rates of treatment completion, and lack 
of systematic information on treatment outcomes. 
Program reviews showed that only 30% of estimated tuberculosis patients were diagnosed 
and only 30% of those were treated successfully. 5 
 
    1.1.2 REVISED NATIONAL TUBERCULOSIS CONTROL 
PROGRAMME (RNTCP) 
On the recommendations of an expert committee, a revised strategy to control TB 
was pilot tested in 1993. The RNTCP applies the WHO recommended Directly 
Observed Treatment, Short-course strategy (DOTS). Full nationwide coverage 
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was achieved in March 2006, covering over a billion people (1164 million) in 632 
districts/ reporting units. 
1.1.2.1OBJECTIVES OF RNTCP 
1. To achieve and maintain a cure rate of at least 85% among newly 
detected infectious (new sputum smear-positive) cases, and 
2. To achieve and maintain detection of at least 70% of all such cases in 
the population.6 
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1. JUSTIFICATION 
 
2.1 INTERNATIONAL STANDARDS FOR TUBERCULOSIS CARE 
The purpose of the International Standards for Tuberculosis Care (ISTC) is to 
describe a widely accepted level of care that all practitioners, public and private, 
should seek to achieve in managing patients who have, or are suspected of having, 
tuberculosis. The Standards are intended to facilitate the effective engagement of all 
care providers in delivering high- quality care for patients of all ages, including those 
with sputum smear-positive, sputum smear –negative, and extra pulmonary 
tuberculosis, tuberculosis caused by drug resistant Mycobacterium tuberculosis 
complex (M. tuberculosis) organisms, and tuberculosis combined with Human 
Immunodeficiency Virus (HIV) infection. 
The basic principles of care for persons with, or suspected of having, tuberculosis are 
the same worldwide: a diagnosis should be established promptly and accurately; 
standardized treatment regimes of proven efficacy should be used with appropriate 
treatment support and monitored; and the essential public health responsibilities must 
be carried out. Thus, all providers who undertake evaluation and treatment of patients 
with tuberculosis must recognize that, not only are they delivering care to an 
11 
 
individual, they are assuming an important public health function that entails a high 
level of responsibility to the community, as well as to the individual patient. 
The Standards should be viewed as a living document that will be revised as 
technology, resources, and circumstances change. As written, the standards are 
presented within a context of what is generally considered to be feasible now or in the 
near future. 
The Standards are also intended to serve as a companion to and support for the 
patients’ Charter for Tuberculosis Care developed in tandem with the Standards. The 
Charter specifies patients’ rights and responsibilities and will serve as a set of 
standards from the point of view of the patient defining what the patient should expect 
from the provider and what the provider should expect from the patient. 
STANDARDS FOR PUBLIC HEALTH RESPONSIBILITIES 
Standard 16 states that all providers of care for patients with tuberculosis should 
ensure that persons (especially children under 5 years of age and persons with HIV 
infection) who are in close contact with patients who have infectious tuberculosis are 
evaluated and managed in line with international recommendations. Children under 5 
years of age and persons with HIV infection who have been in contact with an 
infectious case should be evaluated for both latent infection with M. tuberculosis and 
for active tuberculosis. 7 
Thus, contact screening is a standard of care issue, and not merely an additional 
responsibility of the care providers.  
12 
 
Tuberculosis is almost exclusively transmitted through air from patients with 
pulmonary disease. The risk of transmission is greatest if the index case is ‘‘sputum 
smear positive’’, and is directly proportional to the bacillary density in respiratory 
secretions. Therefore, proximity and persistence of contact are major determinants of 
the risk of transmission of infection, and those living within the same household are at 
higher risk than casual contacts. Among household contacts, those who are very 
young and those with absolute or relative immunodeficiency states are at increased 
risk of acquiring infection from the index case. Delay in the diagnosis and treatment 
of patients increases the risk of disease transmission to their contacts. 8  
Contacts of patients with infectious TB constitute a high-risk group for acquiring M. 
tuberculosis infection, as approximately 30% of close contacts demonstrate evidence 
of infection, and at least half of infected contacts exhibit progression to disease in the 
first 2 years. The risk of acquiring infection with M. tuberculosis among contacts may 
increase with increasing closeness of the contact and with increasing infectivity of the 
index case, resulting from environmental factors such as overcrowding and social 
factors including poverty. Investigations of close contacts of infectious TB patients 
constitute a key target in TB control because they can detect new recent infections 
with M. tuberculosis . Because newly infected contacts are at high risk for progression 
to active TB, contact investigations should be prioritized over other TB screening 
efforts to prevent substantial future TB cases. Household contacts of an infectious TB 
patient are a particularly high-risk population for latent infection with M. tuberculosis 
and for development of active TB. 9 
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Household contacts form a high yield group for selective case finding by radiological 
and other methods of screening. It is always advisable following notification of a case 
of tuberculosis that appropriate contact procedures be initiated with the aim of 
identifying other cases of tuberculosis. If the first notified or index case is one of 
primary tuberculosis, contact tracing is done to locate the source case; and if the index 
case has smear positive post-primary or reactivation tuberculosis, the concern is that 
other contacts may have been infected by the index case, although a source case may 
still be sought. Contacts of a tuberculosis patient are 10 to 60 times more likely to 
have the disease than the general population according to some studies, and 
approximately 10-14% of all notified cases have been detected by contact screening.10 
It is generally accepted that 30% to 50% of household contacts of adults with 
infectious forms of pulmonary TB will become infected. The risk for young children 
with untreated infection to develop TB is up to 43% in children <1 year of age and 
about 24% for children 1 to 5 years of age. 11 
The major risk for contacts lies in exposure to the infectious case before diagnosis.12 
Whereas the first priority of tuberculosis (TB) prevention and control programs is 
identification and treatment of all persons with active TB, the second priority is 
contact investigation to find persons who were exposed to TB patients and to evaluate 
and treat them for latent TB infection (LTBI) and active TB disease.13 
14 
 
Contact investigations continue to be one of the highest yield methods of active case 
finding.14 
Contact investigations are a major cornerstone of public health practice because they 
can detect new TB cases and prevent future cases. Because newly infected contacts 
are at substantial risk for progression to disease, contact investigations should be 
prioritized over other TB screening efforts. Coincident with this prioritization, efforts 
are needed to enhance the effectiveness of contact investigations. Of paramount 
importance is improving the elicitation of contact information from case patients. 
Techniques such as the social network approach, routinely used in sexually 
transmitted disease control, deserve evaluation. Once all contacts have been 
identified, selecting those who are at highest risk of becoming infected and 
progressing to disease requires systematic collection of salient information. The need 
for complete information collection to assess contact risk was underscored by 
Reichler et al, who found that there was documentation of the sputum smear results in 
only 38% of contact records and of the length of exposure to patients in only 1% of 
contact records.  The final and necessary steps in contact investigations are 
completely evaluating contacts for disease and beginning therapy when infection or 
disease is identified. Case contacts have a high risk of developing active TB in the 
first 2 years following infection.10 
The goal of tuberculosis control programmes is to eliminate the disease by breaking 
the chain of transmission, which can be effectively achieved by rapid identification 
and effective treatment of infectious cases. Once these cases are detected, it is 
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imperative to detect infected persons in contact with them so that the chain of 
transmission can be broken. Therefore, in recent years contact tracing has started 
gaining importance and is now incorporated into the Revised National Tuberculosis 
Control Programme of the Government of India.8 
The revised strategy of National Tuberculosis Control Programme lays more 
emphasis on cure of infectious cases. The case finding activities are given lesser 
priority. It is stated that effort at increasing case finding should be made only after 
achieving 85% cure rate in already detected cases. The revised strategy is in line with 
the recommendations made by World Health Organization. This, however, does not 
mean that the contact examination (a case finding activity), which was being carried 
out as a routine practice in various tuberculosis centres should have been 
discontinued, because this activity was available in the centers which also provided 
ideal treatment facilities. Contact examination has a valuable impact on health 
education and impresses on the family and community as a whole, the infectious 
nature of the disease and the need for proper and regular treatment. This results 
ultimately in greater adherence to treatment and improved cure rates. Moreover, 
contacts form an easily approachable group and can be motivated easily.15 
However, in a cross-sectional study conducted in four randomly selected TB units 
(TUs), two in an urban (Chennai City) and two in a rural (Vellore District) area of 
Tamil Nadu, South India, from July to September 2008, it was found that of 220 
contacts aged <14 years, only 31 (14%) had been screened for TB, and that of 84 
household children aged <6 years, only 16 (19%) had been initiated on Isoniazid 
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Prophylaxis Treatment. The treatment cards of source cases lacked documentation of 
contact details.16 
 
Need for conducting a study among household contacts of sputum positive tuberculosis 
patients in a rural area in South India.       
i) There is a scarcity of data regarding adherence to the guidelines regarding 
management of household contacts of sputum positive pulmonary tuberculosis 
patients under the RNTCP. 
ii)  Household contacts form a high risk group for acquiring Tuberculosis infection from 
a case of sputum positive pulmonary tuberculosis. Obtaining data regarding 
contacts may help appropriately reassign Programme priorities. 
iii) Screening of symptomatic household contacts identified by the study may yield new 
cases, thus improving the case detection rate. 
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2. AIMS AND OBJECTIVES 
 
3.1 To study the type of care received by the household contacts of sputum positive pulmonary 
tuberculosis patients in CHAD Tuberculosis Unit in relation to RNTCP guidelines. 
3.2 To assess awareness among patients regarding screening of household contacts of sputum 
positive pulmonary Tuberculosis.   
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3.  LITERATURE REVIEW 
4.1 CONTACT SCREENING IN TUBERCULOSIS 
The rationale for giving high priority to tracing and identification of contacts of newly 
identified tuberculosis patients lies in the relative ease with which such contacts may 
be identified and the expected high prevalence of recently acquired infection in this 
group.17 There are four areas that must be addressed when considering contact 
investigations in countries with high tuberculosis case rates. The first concerns 
epidemiologic issues, the second the diagnosis of latent infection or tuberculosis, 
respectively, in contacts, the third the interventions to be chosen, and finally, how an 
efficient contact investigation scheme can be implemented in a national program. 
It is a widely held conviction that active case finding among contacts of newly 
identified patients with potentially transmissible tuberculosis is an activity with a high 
yield. In industrialized countries it has been shown to be a cost-effective intervention. 
18 In North America, 2–4% of close contacts are commonly found to have clinically 
manifest tuberculosis at the point of investigation,18,13 and up to one third is found to 
be latently infected. Much higher prevalences have been reported when tuberculosis 
was more frequent in industrialized countries and from low-income countries. 12,19-24 
Although contacts of newly diagnosed tuberculosis cases can be found across all age 
groups, the identification of recently acquired infection is more easily distinguished 
from a long-standing infection in younger rather than older contacts. Thus, although 
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infection among contacts is discussed here for various age groups, the emphasis is on 
contacts who are children. 
Table 1. Prevalence of tuberculous infection and tuberculosis among household contacts 
of tuberculosis cases in high incidence settings. 
Study area and 
time 
Index case 
characteristics 
          Contacts examined Prevalence of 
infection     
  n(%) 
Prevalence of 
Tuberculosis  
  n(%) Age group 
(years) 
Number 
examined 
Norway-Oslo, 
1940-53 
76% smear 
positive 
0-4 1012 490(48.4) 224(22.1) 
5-9 607 392(64.6) 167(27.5) 
10-14 499 366(73.3) 83(16.6) 
Korea-Seoul, 
1954 
80% smear 
positive 
0-4 454  62(13.4) 
5-9 470 31(6.6) 
10-19 865 91(10.5) 
India-Madras, 
1956-57 
 0-4 101  25(24.8) 
5-14 163 15(9.2) 
Kenya-Kiambu, 
1959 
Smear positive 0-5 82 24(29.3) 10(12.2) 
6-9 90 54(60.0) 14(15.6) 
10-14 77 52(67.5) 10(13.0) 
India-Tumkur, 
1960-61 
 0-4 69 8(11.6)  
5-9 53 28(52.8) 
10-14 64 40(62.5) 
Incidence (attack rate) over 5 years of follow-up. 
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A study conducted in Kenya in 1959 showed that 30% of children aged less than 6 
years who lived in the same household of a sputum smear-positive case had a 
tuberculin skin test reaction in excess of 8 mm induration.  The prevalence of 
clinically active tuberculosis was several times larger in children who were household 
contacts compared to the general population.24 These findings in Kenya confirm the 
findings from a survey conducted in Tumkur, India, at about the same time. 22 In the 
Indian survey, children aged under 5 years who were household contacts of 
bacteriologically confirmed cases had a prevalence of infection of 12% as compared 
to 2% in children in households without a case. 22 
While prevalence surveys among contacts provide an indication of the magnitude of 
transmission and the prevalence of secondary cases at the point of investigation, this 
underestimates the problem, as cases will continue to emerge over a prolonged period, 
as shown in a pre-chemotherapy study in the United States.25 This emphasizes the 
need to include offering preventive therapy whenever such a screening program is 
carried out. 
Most of these contact investigations have centered around patients with potentially the 
most infectious forms of tuberculosis and contacts living in close proximity with 
them. It must therefore be kept in mind that, judging from extensive and/or modern 
approaches to contact tracing, a considerable proportion of persons recently infected 
by the index case will never be found. 17,26Nevertheless, the available data suggest that 
with some exceptions, investigation of close contacts, particularly children, is a high-
yield activity. 27 
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If children are targeted in a contact investigation scheme, adequately diagnosing 
active tuberculosis can be very difficult. 28 Various scoring methods have been 
proposed to diagnose tuberculosis in children. The method perhaps based on the most 
comprehensive data collection from various countries unfortunately includes  
tuberculin skin testing results, and is thus unlikely to be widely applicable.29 The first 
problem is thus to determine the presence of tuberculosis in a child without tuberculin 
skin testing. In addition, even if tuberculin skin testing is available, an initially 
negative test would require continued follow-up examinations subsequent to 
identification of the index case. In this context it may be noted that in the Madras 
investigation, 8 per cent of the initially tuberculin negative contacts developed 
tuberculosis during the first year of follow-up. 21 
Role of contact examination and implementation of a sensible policy 
High-incidence countries pursue a tuberculosis control strategy which has been 
defined as a strategy primarily targeted at reducing the incidence of tuberculous 
infection through identification of potential transmitters of tubercle bacilli in the 
community, i.e., largely sputum smear-positive cases.30 Using sputum smear 
microscopy among symptomatic contacts of all ages, only 0.8% of cases were found 
among contacts of sputum smear-positive index cases in a study in eastern Nepal.31 
Contact investigations for such cases is thus not a particularly efficient activity: more 
than 100 people must be examined to identify a case in a population (contacts) which 
appears to be at about 10 times the risk of the general population, while only about 
five to 10 tuberculosis suspects spontaneously presenting with relevant symptoms 
need to be examined to identify a case. 32 On the other hand, a study in Malawi 
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identified contact tracing as a highly efficient activity for finding other than infectious 
cases, with a frequency of 7% of cases among contacts of newly identified sources of 
infection. 33 
A model has suggested that identifying and treating even a moderate proportion of 
recently infected persons will accelerate the elimination of tuberculosis much more 
efficiently than preventive therapy of persons with other than recently acquired 
infection. 34 While this generic model probably holds for both high and low-incidence 
countries, the staff in high-incidence countries is often overworked just by the task of 
controlling active, infectious tuberculosis. Importantly, it will not usually be possible 
to identify the majority of recently infected persons through simple case finding 
schemes among readily identified contacts.17 Adding elements of an elimination 
strategy, i.e., identifying persons already infected, must thus be considered very 
carefully. Clearly, any group that is targeted should have an expectedly high 
prevalence of tuberculous infection, be at particularly high risk of progression to 
tuberculosis, and be readily accessible to examination. 
The International Union Against Tuberculosis and Lung Disease (IUATLD) thus 
recommends limiting contact tracing to children under the age of 5 years who live in 
the same household as a sputum smear positive case.35 Those found healthy should be 
given isoniazid and those found ill considered for treatment of active tuberculosis. 
Nothing other than a clinical examination is recommended. There are several reasons 
for this recommendation. First, it targets the most vulnerable group, most likely in 
contact for a prolonged period of time (more so than older children who may be more 
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frequently absent from home). Second, preventive therapy is unlikely to create 
resistance even if a healthy looking child actually has active tuberculosis, as children 
of that age as a rule have a small bacillary load. Finally, the index case can be 
requested to provide preventive therapy to the child. The duration of treatment might 
pragmatically be for the same period as the index case is being treated. In countries 
using 8-month regimens, this duration would be close to optimal. 
Children in close contact with a sputum smear positive case are also logistically one 
of the  most easily accessible groups, and one would think that both the index case 
and the health care provider would agree on the desirability of preventing such 
children from getting tuberculosis. Although the risk of tuberculosis is higher the 
more recent the infection, cases may continue to emerge long after the diagnosis in the 
index case. 36 Thus, reactivation of the infection when such children reach adolescence 
and adulthood might be successfully prevented through early preventive 
chemotherapy. 
This is especially true, considering that in a recent study BCG scars were not 
significantly associated with transmission. Despite vaccination with BCG, a positive 
TST in a child who has had close contact with an infected adult is assumed to most 
likely represent infection with M. tuberculosis. Treatment of this latent infection 
should be considered, especially if the child is younger than 5 years. 37 
Studies have generally shown a grading in the indicators of transmission (active 
tuberculosis and LTBI) by closeness and duration of contact with the infectious 
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source. 38 However,a  recent report found that current factors such as age, size of the 
household, sharing the same bed, number of people living in the same house and BCG 
scars were not significantly associated with the presence of a LTBI. 39  
There is evidence that contagiousness is not an all-or-nothing phenomenon and is 
affected by several factors, only one of which is the bacteriologic status of the 
patient's sputum. Although untreated smear negative, culture positive patients are less 
contagious on average, they still may transmit infection to their close and casual 
contacts. Compared with contacts with tuberculin conversion, persons who are 
already tuberculin positive have much lower risk of developing active tuberculosis 
after exposure, and persons with prior BCG vaccination are at somewhat lower risk.40 
A study conducted in Brazil identified a significant number of people who, due to 
their proximity to the index case, run a great risk of being infected, as principally 
observed in the children of index cases (24.7% of which became infected). 41 
In a study carried out with infant contacts in the same household, it was clear that the 
parents were the most frequent source of infection for the children. Among the 
children who had contact with more than one source of infection, 35.3% developed 
the disease, and, when the source of infection was the mother or the father, 12.4% 
developed the disease. 42 
The contacts who were married or living with steady partners represented the second 
largest category in a study (17.5%), revealing a greater chance of contamination, 
whether they were spouses or partners of the index cases.  
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The risk of developing the disease for a person whose spouse suffers from 
tuberculosis is 2 to 40 times greater than that of the population in general, which 
allows the investigators to conclude that the proximity of the contact is one of the 
important aspects to be considered in the transmission of the bacillus.43 
Various studies have shown the importance of a one- or two-year clinical and 
radiological follow-up evaluation of the contacts of patients with active tuberculosis, 
principally those living under unfavorable socioeconomic conditions. 36 
The clinical form of the index case that was predominant in a study was the 
pulmonary form (seen in 87.3% of the cases), which ratifies the data found in the 
literature showing that the predominant form is the pulmonary form. 44  
Investigators in China have assessed the dose-response relationship between treatment 
delay of smear-positive tuberculosis patients and intra- household transmission. This 
is significant because little is known about the quantitative dose–response relationship 
between delay in TB treatment and household transmission.45 It has been reported that 
a smear-positive patient who is not treated can infect approximately 10 individuals per 
year for an average duration of infectiousness of 2 years.46 Under this circumstance, it 
was thought important to clarify the relationship between delayed TB treatment and 
household transmission. The objective of the study was to document the effect of 
treatment delay on latent TB infection among the household contacts of TB patients. 
A household contact was defined as any person staying in the index case's house for 
more than 3 months before the date of accrual. ‘Total TB treatment delay’ was the 
main independent variable. For TB patients, this was defined as the interval from 
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reported onset of symptoms to commencement of treatment for TB. The median total 
treatment delay of TB index patients was 69 days (mean 89.9 d, SD 62.9 d). Only 15 
patients (3.8%) received anti-TB treatment within 30 days of the onset of their illness, 
whereas the majority (96.2%) had a delay of over 60 days. Three patients (0.8%) 
delayed more than 1 year. For total TB treatment delay, compared with baseline 
contact in univariate analysis, the risk of TST positivity gradually increased with 
prolonged duration of TB treatment delay (crude OR 0.79, 2.31, 3.20 and 3.41 for 
delay ≤30, 30–60, 60–90 and >90 d, respectively). After adjustment for other 
variables in the final model, the effect of treatment delay decreased but remained 
significant [adjusted OR (AOR) 0.61, 1.86, 2.37 and 2.27, respectively]. There was an 
increased risk of TST positivity for contacts of TB patients with chest X-ray 
presenting cavitation (AOR 1.64; 95% CI 1.25–2.21) and for contacts sleeping in the 
same bedroom with the TB patient (AOR 2.29; 95% CI 1.67–2.94). The investigators 
reported that thirty days delay in TB treatment seems to be the turning point at which 
a significant increase in risk for TB infection occurs. The risk of infection increases to 
around 2.3 times as the duration of delay reaches 90 days. Beyond that point the 
infection rate seems to level off.45 
TB has enormous public health and economic implications in high-burden countries. 
There is therefore an urgent need to provide targeted interventions, particularly for 
those most at risk. Screening of household contacts, which has been prioritized in 
industrialized countries, merits serious consideration as a means to interrupt 
transmission in high-burden settings. 
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 In high-prevalence low- and middle-income countries, household contacts have high 
rates of TB (5%) and TB infection (50%). It has been reported that the prevalence of 
TB infection and progression to active TB among household contacts exposed to drug 
susceptible and MDR-TB cases is comparable. Contact investigations could therefore 
be a cost-effective method for early detection of secondary cases of drug resistant 
TB.47 
4.1.1 CLASSIFICATION OF CONTACTS 
In a study conducted in the Tuberculosis Research Centre, Madras (now Chennai), 
contacts were classified into different categories using an elaborate process of 
assessment. Before an index case was accepted for treatment every effort was made to 
interview and examine in the Centre, by radiography and by tuberculin testing, all the 
family members (by blood or marriage) living in the patient's household. In addition, 
family members living elsewhere were sometimes interviewed and examined, either 
because they had attended with the patient or because they had come at the request of 
the medical staff to assist in the assessment of the co-operation to be expected from 
the patient and the immediate family. Although a number of contacts who were 
unrelated to the index case also attended and were examined, the present report is 
confined to a study of the family contacts. At the first and at each subsequent visit of a 
contact a record was made of the then current proximity of the contact to the index 
case, according to the following classification based on the family's cooking and 
accommodation arrangements: 
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 4.1.1.1 GRADING OF CONTACTS       
 
Cooking and feeding     {5 Living in the same room 
       with the Index case               {4 Living in a different room 
   in the same house 
      (3 Living in a different room 
in the same house 
       Cooking and feeding    (2 Living in a different dwelling 
       separately from the   in the same courtyard 
       Index case       (1 Living in a different house in 
the same neighbourhood 
     (0 Living in a different neighbourhood 
 
In addition, the duration of contact during the previous five years, and the period over 
which it had occurred, were recorded. The data so obtained were checked on several 
occasions during the first year of the follow-up, and before undertaking the present 
analysis they were systematically verified. All the family contacts were then classified 
as: 
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(1) " close contacts "-namely, those living, cooking and feeding in the same house as the 
index case (degree of contact 5 or 4) for the period of three months immediately 
preceding the start of treatment for the index case (including infants less than three 
months old); or 
(2) "remote contacts "-namely, all those 5 or 4 degree family contacts who had not been  
in this degree of contact throughout the three months immediately prior to the start of 
treatment for the index case, and all the 3, 2, 1 or 0 degree family contacts.12 
More recently, investigators have sought to classify contacts differently. Typically, 
contacts have been described as being either close contacts or other types of contacts. 
Close contacts could be household contacts, nonhousehold relatives (relatives not living 
in the household) , leisure contacts,  coworkers, or other types of close contacts. 
Interestingly, in a study one-third of TB patients only identified household contacts.13  
Others have described workplace and casual contacts. 64 
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4.2 GUIDELINES ON SCREENING AND MANAGEMENT OF 
CONTACTS 
4.2.1 CONTACTS 
The WHO recommends that TB contacts should be clearly defined in terms of the 
type of contact, and the closeness and duration of exposure to the index case. All 
children in the household, especially those aged under 5 years, should be assessed for 
TB. High priority should also be given to contacts who have HIV infection and those 
with other underlying risk factors for TB. 48  
The RNTCP ,too, categorizes contacts as adult contacts and child contacts, specifying 
different courses of action for each type of contact. 
The RNTCP clearly lists one of the roles ofMedical Officers as emphasizing on all 
sputum positive cases the importance of screening their contacts, and ensure that the 
symptomatic contacts are evaluated. 49 
4.2.2 PROCESS OF CONTACT INVESTIGATION 
All identified prioritized contacts of the index case should be instructed to come to the 
health facility for evaluation. The evaluation may be limited to determining whether 
the contact has symptoms that may suggest TB. As a minimum, all adolescent and 
child contacts should be asked whether they have a persisting cough (>2weeks). 
Sputum smear examination should be carried out on those with a persistent cough. 48  
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Close contacts of multidrug-resistant (MDR) TB patients should receive careful 
clinical follow-up for at least 2 years. If active disease develops, prompt initiation of 
treatment with a regimen designed to treat MDR-TB is recommended. On the basis of 
the currently available evidence, the World Health Organization does not recommend 
second-line drugs for chemoprophylaxis in MDR-TB contacts. 50 
4.2.3 PROVISION OF TREATMENT 
Important considerations to be taken into account when providing treatment. 
i) Any contact identified as having active TB should be registered and treated in line 
with the NTP policy. 
ii) Children aged under 5 years who are close contacts and who do not have evidence of 
TB should be systematically treated with isoniazid chemoprophylaxis: 5mg/kg daily 
for 6 months.  
iii) Children aged 5 years and above who are in good health do not require 
chemoprophylaxis but should be followed up on a clinical basis. 48  
India’s Revised National TB Control Programme (RNTCP) recommends screening of 
all household contacts of smear-positive PTB cases, especially those aged <6 years, 
for symptoms of TB. For asymptomatic children and those found not to be suffering 
from TB disease, daily isoniazid preventive treatment (IPT) at 5 mg/kg is 
recommended for 6 months. To ensure that proper preventive chemotherapy is given 
to children, the Medical Officer should ask (or have the health workers ask) all smear-
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positive PTB patients if they have children aged <6 years and ensure that they are 
brought to a health unit for screening. On the reverse side of the RNTCP TB treatment 
card, the number of household contacts (children aged <6 years) and the number of 
contacts placed on IPT can be recorded. 16   
Table 2. How to proceed with preventive chemotherapy in children under 6 years of 
age who were in contact with a smear positive case. 51 
IF: AND: THEN: 
The child has symptoms of 
tuberculosis 
An MO determines 
(preferably in consultation 
with a pediatrician) that the 
child has tuberculosis 
A full course of anti 
tuberculosis treatment 
(CATIII) should be given.  
 A tuberculin test is not 
available 
The child should receive 
preventive chemotherapy for 6 
months (isoniazid daily- 
5mg/kg body weight). 
A tuberculin test is 
available 
The child should receive 3 
months if INH preventive 
chemotherapy and a tuberculin 
test should then be done. 
IF: THEN: 
The child’s 
induration 
to the 
tuberculin 
test is 
<6mm in 
diameter 
Stop the 
preventive 
chemotherapy 
and give 
BCG 
vaccination 
(if not 
previously 
vaccinated). 
The child’s 
induration 
to the 
tuberculin 
test is 
6mm or 
more in 
diameter 
Continue 
isoniazid 
preventive 
chemotherapy 
for another 3 
months. 
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4.3 CONSIDERATIONS IN CONTACT SCREENING 
Whereas the first priority of tuberculosis (TB) prevention and control programs is 
identification and treatment of all persons with active TB, the second priority is 
contact investigation to find persons who were exposed to TB patients and to evaluate 
and treat them for latent TB infection (LTBI) and active TB disease.13 
Most previous studies pertaining to household contact infection have focused on risk 
factors that are more likely to increase the concentration of the infecting droplets 
suspended in the environment. Those identified factors consist of the severity of 
disease, smear and cavitation status in TB case, family size, intimacy of contact and 
ventilation of the exposure environment.45 
Other studies focused on the nature of possible case–contact interactions, such as 
contact age, immunosuppression and poverty status. 9,13,39,52 
Past studies of contact investigation focused on TB transmission and identification of 
active TB disease among contacts, finding greater transmission of TB infection from 
patients having sputum smear positive(+) for acid-fast bacilli (AFB) 53  and 
prevalence of active TB in 1.3 to 1.5% of adult or household contacts. 54 A contact 
investigation study in Australia examined outcomes other than transmission, finding 
an average of 6.5 contacts screened per patient, a median interval between case report 
and contact screening of 1 month, 36% of contacts as TB infected, and 61% of those 
started on treatment for LTBI as having completed.55 However, a study conducted in 
India provides different figures. In the study, considering the number of close family 
contacts in the 341 families, 12 (3.5%.) of the index cases had no close family 
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contacts and the great majority of the families-namely, 88.3 %/-had five or fewer 
contact members. There were two families with nine contacts, one with 10 and one 
with 14. The average number of contacts for all the families was 3.3. Thus, including 
the index case, the average family consisted of 4.3 members.56 
In a recent study conducted in the USA, the investigators found a median of 
4 (average 6) close contacts per patient, ranging from 2 to 6 among the sites. It was 
noted that a visit by the contact investigation worker to the patient's residence during 
the investigation resulted in identification of two additional close contacts, which were 
likely to be children younger than 6 yr of age.13 
 A Chinese study on screening of household contacts identified a total of 1386 newly 
diagnosed active TB cases. Their 5392 household contacts were screened. The overall 
prevalence of active pulmonary TB among household contacts was 3.76%, but 
significantly higher in the age groups of <15 years or > or =55 years than the other 
age groups (chi2 = 15.381, P < 0.01). The rate of active pulmonary TB in household 
contacts was significantly associated with the amount of bacteria discharged from 
index cases (r = 0.998, P < 0.01). Through contact tracing, every 100 index cases 
could contribute in finding 15 more new active TB cases among household contacts.57 
 In a study conducted in Morocco, more than 1 million household TB contacts were 
identified in approximately 200,000 investigations over a 11 year period. On average, 
77% of identified contacts were screened every year; overall prevalence was 2.5%. 
The proportion of TB cases identified in household contacts of registered cases was 
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5.6%. This was significantly higher in children under 10 years and in patients 
registered and diagnosed with symptomatic primary complex.47 
Another study reported that the prevalence of tuberculosis infection among the 
contacts was 44% (763/1733). Tuberculin conversion was observed in 7.8% of 
contacts, and 31 new cases of tuberculosis were detected (1.8%). The percentages of 
tuberculosis infection, tuberculin conversion and case detection were higher among 
persons exposed to sputum smear-positive patients and among those in close contact 
with the index case. Contact infection was more highly associated with the 
bacteriological status of the index case and degree of proximity of exposure when the 
analysis was restricted to contacts less than 15 years old. Case detection was 4% 
among close contacts living with a sputum smear-positive patient. 
The authors concluded that investigation into tuberculosis contacts offered a high 
yield of detection of infected contact persons and new tuberculosis cases, even among 
contacts of culture-negative pulmonary tuberculosis patients and contacts of 
extrapulmonary tuberculosis patients.58 
A study conducted in Pakistan recently reported that household contacts of patients 
suffering from active pulmonary tuberculosis have more chances of being infected 
with Mycobacterium tuberculosis as compared to the healthy non-contact, as shown 
by the higher levels of antituberculous antibodies & positivity of Mantoux test.59 
Another study  was conducted to evaluate the risk for household contacts of 
tuberculous patients as compared to non-contacts.the investigators found that there 
was no difference in the average age of the household contacts and non-contacts. The 
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complaints of pyrexia, night sweats and weight loss were more in house hold contacts 
as compared to non-contacts. The awareness about BCG vaccination was equal in 
both. There were 49 contacts with positive Mantoux test while negative Mantoux test 
was found in 71 contacts. There were only three Mantoux positive among eighty non-
contacts. There was no significant difference in the presence of IgM among household 
contacts as compared to non-contacts. However both IgG and IgA were present in 
significantly higher number of household contacts compared to non-contacts.9  
More recently, other aspects of contact screening have begun receiving attention. A 
study in the USA  identified several TB program practices or characteristics correlated 
with successful outcomes of contact investigation. One, the greater number of close 
contacts identified for drug-resistant and cavitary TB patients suggests that contact 
investigation workers expend greater efforts to identify close contacts of these 
patients. By doing this, TB programs reduce the risk of there being undiagnosed drug-
resistant patients and prevent future disease among contacts, as well as identify the 
many infected contacts to potentially highly infectious patients. Two, a visit by the 
contact investigation worker to the patient's residence results in the identification of 
two additional (especially child) close contacts. Three, recording the date of last 
exposure to the infectious patient facilitates provision of follow-up TSTs to contacts 
initially TST( ), which is necessary to identify all contacts likely to convert to 
TST(+). Four, sites that use PHNs are more likely than those using outreach workers 
to start TST( /unknown) high-risk contacts, who are possibly infected but anergic, or 
TST converters before their follow-up TSTs on presumptive treatment for LTBI. Five, 
the use of DOT increases the likelihood of LTBI treatment completion.13 
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Most recently, the updated summary of the Stop TB Strategy mentions: 
Component 2. Address TB/HIV, MDR-TB and the needs of poor and vulnerable 
populations 
a. Scale up collaborative TB/HIV activities. 
b. Scale up prevention and management of MDR-TB. 
c. Address the needs of TB contacts, and of poor and vulnerable populations.60 
d. Clearly, the revision reflects the increasing concern about TB contacts among policy 
makers at the global level. 
 
4.4 AWARENESS OF CONTACT SCREENING 
In a recent study conducted in Tamil Nadu, the investigators attempted to ascertain 
the prevalence and awareness of contact screening among patients and health care 
workers. 
Awareness about RNTCP contact screening and IPT policies among source cases was 
studied by an interview conducted in the local language (Tamil) by trained field 
investigators using a semi-structured interview schedule. This contained questions on 
the duration of symptoms, awareness of risk of transmission to family contacts, 
number of close contacts—especially children aged <6 years, screening for TB among 
children aged 0–14 years by symptom elucidation and relevant investigations (chest 
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X-ray, sputum examination), initiation of chemoprophylaxis, and treatment adherence 
and completion.16 
There is currently no provision for documentation of the details of contact screening, 
IPT administration and follow-up, and these details therefore could not be elicited 
from the TB treatment card of the source case. The patient interview was thus 
considered as the most reliable source of information. 
The study findings revealed that the knowledge that TB is transmissible to other 
family members was significantly lower among rural than urban patients (25/118, 
21% vs. 113/135, 84%, P < 0.001). Among the 220 contacts aged 0–14 years, only 31 
(14%) had been screened for TB disease. None of the child contacts screened was 
diagnosed with active TB disease. Of the 55 patients who had children aged <6 years, 
only 15 (27%) stated that they had been informed about the provision of IPT for their 
children.16 
Another study conducted in Laos found that the awareness of the infectiousness of TB 
was low (30%) in case-patients, adults and child contacts. This raises questions about 
the quality of the given counseling and health education during DOTS at the 
concerned hospitals. This low level of awareness might explain the persistence of 
risky behavior such as indiscriminate spitting and close contacts while coughing or 
sleeping. Both, low awareness and risky behavior, might have contributed to the high 
proportion of LTBI in contact children in the study.61 
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4.5 MANAGEMENT OF SCREENED CONTACTS 
 
Experience in IUATLD collaborative programs shows that most national programs 
have written recommendations in their manuals to offer preventive therapy to children 
under the age of 5 years who are in close contact with a newly discovered sputum 
smear positive case. Yet, the policy is rarely implemented. Only rarely are children 
who are household contacts called upon and examined, and preventive therapy in this 
group is rarely utilized (IUATLD, unpublished data). This rather disappointing 
observation may reflect the uncertainty about the role and the impracticality of contact 
investigations in high burden settings. It also indicates that the role of preventive 
therapy for groups that are more difficult to identify, in whom the risk of tuberculosis 
is lower or the risk of monotherapy higher, must be relegated to a lower priority for 
contact investigations as long as the most readily identifiable group, with a high 
disease risk and low risk of adverse events from the interventions (i.e., small children 
who are contacts of newly identified cases),is not routinely evaluated and treated.27 
In a study conducted in South India, among children aged <6 years, only 16 (19%) 
had been initiated on IPT, with no difference between rural and urban groups.16 
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4. METHODOLOGY 
4.1 DEFINITION OF TERMS 
 HOUSEHOLD CONTACTS 
 Those living, cooking and feeding in the same house as the index case for the period 
of three months immediately preceding the start of treatment for the index case 
(including infants less than three months old).12 
 INDEX CASE 
 The first member of a family suffering from sputum positive pulmonary tuberculosis 
to be registered in a DOTS Center. 
  SPUTUM POSITIVE PULMONARY TUBERCULOSIS 
 Sputum smear examination shows the presence of Acid Fast Bacilli on Ziehl- 
Neelson staining in at least one sputum sample. 
 
   DISTRICT TUBERCULOSIS CENTRE (DTC) 
The District Tuberculosis Centre (DTC) is the nodal point for TB control activities in 
the district and also functions as a specialised referral centre. 
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The District Tuberculosis Officer (DTO) has the overall responsibility to implement 
the programme at the district level and is assisted by a Medical Officer (MO) and 
other technical and administrative staff. 
    TUBERCULOSIS UNIT (TU) 
This is the sub-district unit of TB control activities and is usually based in health 
institutions such as Community Health Centres (CHC), Taluk Hospitals or Block 
PHCs. The population covered is approximately 5 lakhs (2.5 lakhs in hilly, tribal and 
difficult areas). A Senior Treatment Supervisor (STS) and a Senior TB Laboratory 
Supervisor (STLS) are based at the TU. 
     DESIGNATED MICROSCOPY CENTRE (DMC) 
Designated Microscopy Centres (DMC) are usually situated at tertiary and secondary 
level health care institutions and Block PHCs or other equivalent institutions 
including private and NGO facilities. Each usually caters to a population of 1 lakh 
(0.5 lakh in hilly, tribal and difficult areas). 
PERIPHERAL HEALTH INSTITUTIONS (PHIs) 
For the purpose of RNTCP, a PHI is a health facility which is manned by at least a 
medical officer (even if the post is currently vacant). At this level are the dispensaries, 
PHCs, CHCs, referral hospitals, major hospitals, specialty clinics/ hospitals (including 
other health facilities)/ TB hospitals/ Medical Colleges within the District. All health 
facilities in the private/ NGO sector participating in RNTCP are also considered as 
PHIs under the programme. Some of these PHIs will also be DMCs.6 
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5.2 SETTING 
The study was conducted in the Community Health And Development 
(CHAD) Tuberculosis Unit (TU). This tuberculosis unit is the redesignated 
Kaniyambadi Tuberculosis Unit, and is located in the premises of the CHAD 
Hospital, Bagayam. CHAD Hospital is the base hospital for the Department of 
Community Medicine of the Christian Medical College, Vellore. The Hospital  
primarily caters to the people of Kaniyambadi Block, but also receives patients 
from other areas of Vellore and Tiruvannamalai Districts. The CHAD 
Tuberculosis Unit caters to a population of 615,013 people.This was the base 
population for the duration of the study. 
The details of Designated Microscopy Centres and the attached PHIs within 
the TU are given in Table4. 
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Table 3. Details of Designated Microscopy Centres and PHIs in CHAD TU 
No. Designated Microscopy Centre ATTACHED PHI(s) 
1. ALANGAYAM 
Alangayam PHC 
Nimmiyampet PHC 
Kavanur PHC 
Pudur Nadu PHC 
2. CHAD CHAD Hospital, Bagayam 
3. GVMCH GVMCH, Adukkamparai 
4. KAMMAVANPET Kammavanpet PHC 
5. KANIYAMBADI Kaniyambadi PHC Kathalampet PHC 
6. ODUGATHUR Anaicut PHC Odugathur PHC 
7. PALLIKONDA Pallikonda PHC Poigai PHC 
8. SRI NARAYANI HOSPITAL Sri Narayani Hospital, Thirumalaikodi
9. USSOOR Alamelurangapuram PHC Ussoor PHC 
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5.2 STUDY DESIGN 
The study is a cross-sectional study assessing the type of care received by household 
contacts of sputum positive pulmonary tuberculosis patients registered with CHAD 
TU. As part of the study, the investigator came in contact with the patients only once- 
during the interview. 
 
5.3 STUDY METHOD 
Direct interview with the respondents. 
 
5.4 STUDY INSTRUMENT 
Questionnaire administered by the investigator. 
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5.5 INCLUSION AND EXCLUSION CRITERIA 
INCLUSION CRITERIA: 
i) All sputum positive pulmonary Tuberculosis patients, more than 18 years of 
age, and 
ii) Registered with the CHAD TU between July 2008 and June 2010. 
 
EXCLUSION CRITERIA: 
All sputum positive pulmonary Tuberculosis patients, more than 18 years of age, 
and registered with the CHAD TU between July 2008 and June 2010, who were 
unwilling to participate in the study. 
 
5.6 OUTCOME MEASURES 
The following outcome measures were studied: 
i) Number of patients advised contact screening. 
ii) Number of instances where contact screening was done. 
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iii) Number of instances where child contacts were initiated on IPT. 
iv) Number of patients aware of the need to screen household contacts. 
v) Number of patients aware of methods to perform contact screening. 
 
5.7 SAMPLE SIZE CALCULATION 
Sample size calculation done using the formula:  4 pq/ d²  
Where p= prevalence 
And d= precision 
Assuming a contact screening rate of 30% 
Precision:10% 
Sample size: 4 (0.3*0.7)/(0.1*0.1) =84  
 
5.8 DATA COLLECTION AND ANALYSIS  
The proposal for the study was prepared and submitted to the Institutional Research 
Board, Christian Medical College, Vellore. The board approved the study.(Approval 
letter in Appendix 1.) 
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The questionnaire for the study was prepared and pre-tested in a pilot survey. 
Modifications were made to the questionnaire based on the experience of the pilot 
survey. 
The investigator obtained the list of all sputum positive patients registered with the 
CHAD TU between July 2008 and June 2010 from the TB Register maintained at the 
TU. The addresses were entered into a specially created database using Microsoft 
Excel 2007. 
Next, the addresses were scrutinised for completeness. The TU covers a vast area, 
hence the addresses were sorted by geographical location. This included sorting by 
place of residence/village and Block. 
A list of all addresses was prepared for each calendar year, sorted according to the 
place of residence/ village Block. 
The addresses have been classified into the following groups on the basis of follow-up: 
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Table 4. Classification of addresses included in the study 
Serial Number Type of Address Description 
1. Contacted The investigator verified the accuracy of the 
address either directly, or through Health 
Aide/ Volunteers. 
2. Interviewed The investigator interviewed the patient after 
obtaining written consent. 
3. Unable to contact The investigator was unable to contact the 
patients at their given addresses, and was 
unable to obtain any further information 
regarding their whereabouts. 
4. Unavailable The address was correct. However, the patient 
was not at home on at least 2 occasions. 
These patients could not be interviewed. 
5. Migrated The address was correct, but the patient does 
not reside there anymore. If the present 
address was known, the patient was traced at 
the new address and included as “contacted”. 
6. Unwilling The patients at these addresses did not give 
consent to participate in the study. 
7. Died The address was correct, but the patient had 
died. The investigator confirmed the status of 
the patient with survivors of the patient’s 
family. 
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The investigator then proceeded to physically verify the addresses by systematically 
covering all the villages in a Block before moving on to the next one. 
Extreme care was taken to maintain the confidentiality of the patient. The investigator 
divulged the purpose of the visit only to the patient, after confirming that the person in 
question had received treatment for tuberculosis. Direct references to the illness were 
avoided whenever others were in the vicinity of the patient. Patients were asked 
whether they had obtained treatment from the Peripheral Health Institution that was 
purported to have provided DOTS, following which they were asked whether they had 
received treatment for Tuberculosis. If they responded in the affirmative, the 
investigator enquired whether other family members were aware of the illness. In 
situations where the patients had not disclosed their disease status to other family 
members, the patients were given the option of being interviewed at a neutral location. 
Many patients residing near the CHAD Hospital preferred being interviewed at 
CHAD Hospital; others were interviewed at a discrete location of their choice. In all 
other situations where the family was aware of the disease status, the interview was 
conducted in the patient’s home. 
The investigator then proceeded to explain the details of the study to the patient. 
Printed information sheets (in Tamil) were given to the patient. Written consent was 
obtained only after the patient’s doubts/ concerns were fully clarified. On some 
occasions the patient was either residing alone, or had not disclosed the disease status 
to others. In such situations the investigator was unable to obtain the signature of a 
witness. 
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The questionnaire was administered by the investigator, and responses entered on the 
spot. 
The questions asked pertained to general patient details, details of treatment and 
screening, and awareness regarding contact screening. In addition, details of all 
contacts were obtained. All child contacts were examined for the presence of BCG 
scar, and details regarding Isoniazid Prophylaxis Treatment(IPT) were obtained. 
Wherever there was a child contact, or any symptomatic adult contact, the investigator 
referred the individual for screening. The said individuals were advised to go to the 
nearest Microscopy Centre or CHAD Hospital, according to their preference.  
In addition, the investigator encountered patients who had completed their stipulated 
course of ATT, but who had not tested sputum following treatment completion; those 
who had defaulted on treatment, and those who were symptomatic again after being 
cured. These patients were also referred for further management to CHAD. 
Data entry was done using Microsoft Excel and SPSS version 15. 
Analysis was done using SPSS version 15.0. 
6. RESULTS 
6.1 BASELINE CHARACTERISTICS 
The year wise break-down of patients is given in Table 5. 
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Table 5. Distribution of patients by year and inclusion status. 
YEAR TOTAL SPUTUM 
POSITIVE 
PATIENTS 
NUMBER OF 
ADDRESSES 
INCLUDED 
NUMBER OF 
ADDRESSES NOT 
INCLUDED 
2008 167 131(78.4%) 36(21.6%) 
2009 236 187(79.2%) 49(20.8%) 
2010 160 20(12.5%) 140(87.5%) 
TOTAL 563 338(60.0%) 225(40.0%) 
Inclusion was stopped on obtaining the required sample size. 
 All values in brackets are the respective numbers expressed as a percentage 
of the total patients in the corresponding year. 
 
 
 
 
 
 
Table 6. Details of patients included in the study 
YEAR TOTAL 
PATIENTS 
INCLUDED 
NUMBER OF  
ADDRESSES 
UNABLE TO 
CONTACT 
ADDRESSES CONTACTED 
NUMBER OF 
MIGRATED/ 
UNAVAILABLE 
NUMBER 
OF DEAD 
NUMBER OF 
UNWILLING
NUMBER 
INTERVIEWED 
TOTAL  
ADDRESSES 
CONTACTED 
2008 131 91(69.5%) 5(3.8%) 10(7.6%) 5(3.8%) 20(15.3%) 40(30.5%) 
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2009 187 95(50.8%) 7(3.7%) 27(14.4%) 5(2.7%) 53(28.3%) 92(49.2%) 
2010 20 5(25.0%) 2(10.0%) 1(5.0%) 1(5.0%) 11(55.0%) 15(75.0%) 
TOTAL 338 191(56.5%) 14(4.1%) 38(11.2%) 11(3.2%) 84(24.9%) 147(43.5%) 
  All values in brackets are the respective numbers expressed as a percentage of the total 
patients in the corresponding year.
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Figure 1. Flow chart of patients  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TOTAL SPUTUM 
POSITIVE PATIENTS IN 
CHAD TU REGISTER 
(563) 
TOTAL NUMBER OF PATIENTS 
INCLUDED IN STUDY (338) 
TOTAL ADDRESSES 
UNABLE TO CONTACT 
(191) 
TOTAL ADDRESSES 
CONTACTED (147) 
TOTAL MIGRATED OR 
UNAVAILABLE (14) 
TOTAL DIED (38) 
TOTAL UNWILLING (11) 
TOTAL INTERVIEWED 
(84) 
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Table 7. Characteristics of Patients Interviewed (N=84) 
CHARACTERISTIC NUMBER (%) 
AGE 
                              
18-45 37(44.0%) 
46-60 29(34.5%) 
>60 18(21.4%) 
SEX MALE 61(72.6%) 
FEMALE 23(27.4%) 
EDUCATION NIL 15(17.9%) 
1-5 17(20.2%) 
6-10 40(47.6%) 
11-12 8(9.5%) 
ITI/DIPLOMA 3(3.6%) 
POST GRADUATE 1(1.2%) 
OCCUPATION 
 
UNEMPLOYED 35(41.7%) 
UNSKILLED LABOUR 12(14.3%) 
SKILLED LABOUR 24(28.6%) 
BUSINESS/ SELF 
EMPLOYED 
6(7.1%) 
GOVT. SERVICE 6(7.1%) 
PROFESSIONAL 1(1.2%) 
MARITAL 
STATUS 
SINGLE 13(15.5%) 
MARRIED 57(67.9%) 
WIDOW/ WIDOWER 8(9.5%) 
DIVORCED/SEPARATED 6(7.1%) 
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Table 8. Characteristics of Patients Interviewed (N=84) 
CHARACTERISTIC NUMBER (%) 
DOTS CATEGORY CATEGORY I 54(64.3%) 
CATEGORY II 27(32.1%) 
CATEGORY IV 
(MDR-TB) 
3(3.6%) 
DISTANCE FROM 
PHI(KM) 
UPTO 5 55(65.5%) 
6-10 20(23.8%) 
11-15 8(9.5%) 
16-20 0(0.0%) 
>20 1(1.2%) 
FAMILY HISTORY 
OF TB 
PRESENT 57(67.9%) 
ABSENT 27(32.1%) 
TOTAL NUMBER 
OF CONTACTS 
(N=249) 
MALE 179(71.9%) 
FEMALE 70(28.1%) 
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6.2 ADVISED TO UNDERTAKE CONTACT SCREENING 
 
26, 31%
58, 69%
FIGURE 2. PATIENTS BY ADVISE TO SCREEN CONTACTS (N=84)
ADVISED SCREENING
NOT ADVISED SCREENING
 
The above figure shows the details of patients by advise to screen contacts. As can be 
seen, only 26(31%) of the respondents were advised to screen their contacts. 
6.3 SCREENED CONTACTS 
19, 23%
65, 77%
FIGURE 3. NUMBER OF PATIENTS BY CONTACT SCREENING (N=84)
CONTACTS SCREENED
CONTACTS NOT SCREENED
The above figure shows details of patients by contact screening status. Only 19(23%) 
of the respondents undertook screening of their contacts.  
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6.4 AWARENESS THAT CONTACTS NEED TO BE SCREENED 
65, 77%
19, 23%
FIGURE 4.  PATIENTS BY AWARENESS THAT CONTACTS NEED TO BE SCREENED 
(N=84)
AWARE
NOT AWARE
 
The above figure shows details of patients by awareness that contacts need to be 
screened. Of the respondents, 65(77%) were aware of the need to screen contacts. 
 
6.5 AWARENESS ON HOW TO SCREEN CONTACTS 
45, 69%
20, 31%
FIGURE 5. PATIENTS BY AWARENESS ON HOW TO SCREEN CONTACTS(N=65)
AWARE
NOT AWARE
 
The above figure shows details of patients by their awareness regarding how to screen 
contacts. 45(69%) of th respondents are aware of methods to screen contacts for 
tuberculosis.  
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Table 9. SUMMARY TABLE OF FACTORS CONTRIBUTING TO PATIENTS 
BEING ADVISED TO UNDERTAKE CONTACT SCREENING (N=84) 
FACTOR ODDS RATIO (95% C.I.) p VALUE 
MALE 1.023(0.497-2.106) 0.950 
18-45 YEARS 0.932(0.487-1.781) 0.830 
EDUCATED 0.489(0.264-0.907) 0.039 
EMPLOYED 0.974(0.511-1.858) 0.936 
MARRIED 1.066(0.532-2.137) 0.857 
UPTO 5 KM 
FROM PHI 
0.527(0.283-0.984) 0.046 
SYMPTOMATIC OR 
CHILD 
CONTACTS 
PRESENT 
 
2.743(1.528-4.924) 
 
0.001 
CHILD CONTACT 
PRESENT 
 
2.509(1.395-4.510) 
 
0.004 
FAMILY HISTORY 
OF TB PRESENT 
 
0.938(0.468-1.881) 
 
0.857 
ANY CAT II/ CAT 
IV 
1.543(0.823-2.893) 0.181 
ANY EVER 
TREATED 
DEFAULT/ 
FAILURE/ 
RELAPSE 
 
 
1.333(0.682-2.607) 
 
 
0.414 
ANY DEFAULT 1.105(0.677-1.345) 0.785 
Details of analysis cross-tabulations by various factors and outcome measures are 
present in Appendix 2. 
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Table 10. SUMMARY TABLE OF FACTORS CONTRIBUTING TO 
PATIENTS UNDERTAKING CONTACT SCREENING (N=84) 
FACTOR ODDS RATIO (95% C.I). p VALUE 
MALE 1.414(0.524-3.817) 0.482 
18-45 YEARS 0.924(0.414-2.061) 0.846 
EDUCATED 1.159(0.386-3.481) 0.789 
EMPLOYED 0.519(0.233-1.157) 0.103 
MARRIED 1.776(0.651-4.845) 0.239 
FAMILY HISTORY 
OF TB 
PRESENT 
1.535(0.699-3.374) 0.291 
 SYMPTOMATIC OR 
CHILD CONTACTS 
PRESENT 
 
6.933(3.033-15.850) 
 
<0.001 
CHILD CONTACTS 
PRESENT 
 
5.865(2.690-12.787) 
 
<0.001 
EVER TREATED 
RELAPSE/ 
DEFAULT/ 
FAILURE 
 
2.700(1.272-5.733) 
 
0.010 
ANY DEFAULT 0.800(0.298-2.145) 0.651 
UPTO 5KM FROM 
PHI 
1.476(0.590-3.692) 0.392 
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Table 11.SUMMARY TABLE OF FACTORS POTENTIALLY INFLUENCING 
AWARENESS OF CONTACT SCREENING (N=84) 
FACTOR ODDS RATIO (95% C.I.) p VALUE 
MALE 1.155(0.858-1.555) 0.293 
18-45 YEARS 1.310(1.045-1.641) 0.022 
EDUCATED 2.138(1.142-4.003) <0.001 
EMPLOYED 1.396(1.060-1.839) 0.007 
MARRIED 0.992(0.776-1.269) 0.952 
FAMILY 
HISTORY OF 
TB PRESENT 
 
1.319(1.080-1.612) 
 
0.022 
 SYMPTOMATIC OR 
CHILD 
CONTACTS 
PRESENT 
 
1.322(1.100-1.588) 
 
0.031 
CHILD CONTACTS 
PRESENT 
 
1.310(1.090-1.575) 
 
0.040 
EVER TREATED 
FAILURE/ 
DEFAULT/ 
RELAPSE 
 
1.063(0.828-1.363) 
 
0.651 
ANY DEFAULT 0.824(0.595-1.140) 0.175 
ANY CAT II/ IV 1.054(0.834-1.331) 0.669 
UPTO 5KM FROM 
PHI 
0.963(0.760-1.220) 0.759 
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Table 12.SUMMARY TABLE OF FACTORS POTENTIALLY INFLUENCING 
AWARENESS OF HOW TO SCREEN CONTACTS (N=65)  
FACTOR ODDS RATIO (95% C.I.) p VALUE 
MALE 0.23(0.545-0.959) 0.068 
18-45 YEARS 1.108(0.800-1.536) 0.535 
EDUCATED 1.042(0.578-1.881) 0.886 
EMPLOYED 1.023(0.723-1.447) 0.896 
MARRIED 0.865(0.628-1.191) 0.401 
UPTO 5KM 
FROM PHI 
1.213(0.834-1.762) 0.280 
SYMPTOMATIC OR 
CHILD 
CONTACTS 
PRESENT 
 
0.984(0.686-1.410) 
 
0.928 
CHILD CONTACTS 
PRESENT 
 
0.949(0.652-1.383) 
 
0.782 
FAMILY HISTORY 
OF TB PRESENT 
 
1.169(0.852-1.605) 
 
0.350 
ANY CAT II/ IV 1.037(0.745-1.444) 0.830 
EVER TREATED 
RELAPSE/ 
DEFAULT/ 
FAILURE 
 
1.027(0.715-1.474) 
 
0.888 
ANY DEFAULT 0.788(0.485-1.278) 0.269 
 
 
 
The factors found to have significant influence on the outcome measures were 
included in a logistic regression framework. Since there were no factors significantly 
influencing the awareness regarding how to screen contacts, that outcome measure 
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was excluded from logistic regression. Multiple logistic regression was performed for 
the following outcome measures: patients being advised to undertake contact 
screening; patients undertaking contact screening; patients’ awareness regarding the 
need to screen contacts. 
 
Table 13. Multiple Logistic Regression Analysis for a patient being advised to 
undertake contact screening 
 B OR(95% CI) Significance 
(p) 
EDUCATED 1.472 4.358(1.192-
15.935) 
0.026 
RESIDENCE 
UPTO 5KM 
FROM PHI 
0.995 2.706(0.924-
7.925) 
0.069 
SYMPTOMATIC 
CONTACTS 
PRESENT 
-1.890 0.151(0.047-
0.489) 
0.002 
 
Table 14. Multiple Logistic Regression Analysis for a patient undertaking contact 
screening 
 B OR(95% CI) Significance 
(p) 
SYMPTOMATIC 
CONTACTS 
PRESENT 
-2.817 0.060(0.017-
0.216) 
<0.001 
EVER TREATED 
RELAPSE/ 
DEFAULT/ 
FAILURE 
-1.225 0.294(0.077-
1.123) 
0.073 
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Table 15. Multiple Logistic Regression Analysis for a patient being aware of the need to 
undertake contact screening 
 B OR(95% CI) Significance 
(p) 
SYMPTOMATIC 
CONTACTS 
PRESENT 
-2.358 0.095(0.009-0.983) 0.048 
FAMILY 
HISTORY OF 
TB PRESENT 
-0.534 0.586(0.098-3.510) 0.559 
EMPLOYED -1.335 0.263(0.075-0.928) 0.038 
EDUCATED -1.817 0.162(0.036-0.725) 0.017 
18 TO 45 YEARS -0.380 0.684(0.159-2.943) 0.610 
 
 
 
6.6 MANAGEMENT OF CHILD CONTACTS 
Table 16. Details of Child Contacts 
TOTAL 
NUMBER 
OF CHILD 
CONTACTS 
NUMBER OF 
CHILD 
CONTACTS 
NOT 
SCREENED 
NUMBER OF CHILD CONTACTS SCREENED 
RECEIVED 
IPT 
DID NOT 
RECEIVE 
IPT 
RECEIVED 
ATT 
TOTAL 
23 7(30.4%) 7(30.4%) 7(30.4%) 2(8.8%) 16(69.6%)
IPT= Isoniazid Prophylaxis Treatment 
ATT=Anti Tuberculosis Treatment 
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Table 17. Details of referrals 
CATEGORY NUMBER REFERRED NUMBER CAME TO 
CHAD 
PATIENTS 25 10(40.0%) 
CHILD CONTACTS 9 5(55.6%) 
SYMPTOMATIC ADULT 
CONTACTS 
6 3(50.0%) 
TOTAL 40 18(45.0%) 
 
 
 Table 18. Details of contacts who came to CHAD Hospital (N=8) 
 
As Table 18. shows, of the 6 symptomatic adult contacts referred to CHAD, 
3(50.0%) came for screening. Of these, 2(66.7%) were diagnosed to be 
sputum positive for Acid Fast Bacilli. The excess yield is 2.4%.  
 
 
CATEGORY TOTAL 
NUMBER 
SEEN IN 
CHAD 
SCREENING 
METHOD 
          TEST RESULT OUTCOME 
NUMBER 
POSITIVE 
NUMBER 
NEGATIVE 
CHILD 
CONTACTS 
5 MANTOUX 
TEST 
0(0%) 5(100%) STARTED ON INH 
PROPHYLAXIS 
SYMPTOMATIC 
ADULT 
CONTACTS 
3 SPUTUM AFB 
X 2  
2(66.7%) 1(33.3%) SPUTUM 
POSITIVE 
PATIENTS 
STARTED ON 
CAT I DOTS 
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7. DISCUSSION 
 
The characteristics of patients in this study (Table 7.) indicate that 61(72.6%) of all 
respondents were male. Other studies have reported the proportion of male 
respondents as ranging from 66.2% 45  to 75% 8,13,16,61 
The proportion of Category I patients was observed to be 54(64.3%). Investigators 
have reported 80% 16. 
The mean age of respondents was found to be 46.6. This compares well with the 
reports of other investigators.16,61   
The mean distance from the residence to the PHI providing treatment was found to be 
5.29Km. This compares well with another study where the mean distance to the 
nearest health care facility was reported to be 4.7Km.61 
The total number of contacts was 249, of which 61.8% were female. There were an 
average of 2.9 contacts per respondent. Elsewhere, investigators have found the 
average number of contacts to range from 3.3 56, 3.6 12, 6 13. However, the studies 
conducted in India are closer to the observed value. 12,56  
Overall, the findings on the baseline characteristics of respondents and their contacts 
seem to agree with those from other studies.  
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In this study, only 31% of all respondents had ever been advised to undertake contact 
screening (Figure 2.) 
The results of the study (Figure 3.) indicate that the initial assumption that contact 
screening is being performed in only upto 30% instances (approx.) is true. The rate of 
contact screening in this study is 23%. In comparison, the prevalence of contact 
screening has been variously reported as 24-77%. 16,62  The value obtained correlates 
with that reported by Banu et al (study conducted in Tamil Nadu, with respondents 
from Chennai and Vellore).16 
Among various reasons cited for the low rates of contact screening in India, low levels 
of awareness as well as poor motivation among health care workers to actually follow 
the guidelines stand out.16 
In studies conducted in Africa, investigators reported distance, poverty and lack of 
facilities to conduct screening as major factors for lack of contact screening.  
Interestingly, of all those who undertook contact screening, 8(42%) had not been 
advised to do so.  
In this study, being advised to screen one’s contacts is significantly associated with 
education and the presence of symptomatic or child contacts.(Table 13.) 
Those who are educated are 4.35 times more likely to be advised to undertake 
screening of their contacts(p=0.026).  
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However, the presence of a symptomatic or child contact during treatment protects 
against being advised to undergo contact screening (OR 0.151, 95% CI 0.047-0.489; 
p=0.002).    
The implications of the above findings are two-fold:  
i) The fact that literate patients are more likely to be advised to undertake contact 
screening is a double-edged sword. On the one hand, in regions where literacy rates 
are high, most patients will be advised to undertake contact screening. This will likely 
result in the detection of more patients. However, considering the reluctance of the 
health care workers to actually conduct the screening, it is unlikely to significantly 
impact the case detection rates. The burden of disease is likely to continue to remain 
unchanged, with a large number of patients undetected and untreated. On the other 
hand, in areas with low literacy rates, more individuals are likely to not be advised to 
undertake contact screening. These individuals are then likely to be detected at 
advanced stages of the disease, or after having received non-standard treatment. This 
will potentially increase the risk of mortality due to the disease, as well as the risk of 
developing a drug-resistant form of TB. Either situation doesn’t bode well for the 
long-term success of the RNTCP. 
ii) The significance of having a child or symptomatic contact resulting in the respondent 
not being advised to undertake contact screening lies in the fact that it is this high-risk  
group that actually needs to be advised and screened. However, in view of the low 
overall rate of screening, it seems reasonable to assume that many contacts are not 
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benefiting from this. The possible explanations for the finding that the presence of a 
symptomatic or child contact is likely to result in the patient not being advised to 
undertake contact screening are: 
a) Not many (31% in this study) patients are being advised to undertake contact 
screening in the first place. 
b) There is thus a higher chance that those with such contacts will be missed by 
the system under the present circumstances. 
c) The patients themselves may not be disclosing the truth regarding their 
contacts even if they are asked about them. A study62 revealed that patients 
were likely to bring their contacts to the health centre if there was a high 
intention to do so (Adjusted OR = 3.35, 95% Cl = 1.44-7.76). With many 
patients reluctant to disclose their disease status to even their closest family 
members, it is quite possible that patients deliberately withhold such 
information as might cause them to either disclose their disease status, or take 
other family members to the hospital for screening.      
The factor that significantly influences the decision to actually undertake screening of 
the household contacts is the presence of a symptomatic or child contact (OR 
0.060(0.017-0.216) (p=<0.001). However, as discussed above, the presence of a 
symptomatic or child contact is likely to cause the patient not to undertake screening. 
While this may appear counter-intuitive, the fact is that most patients prefer to receive 
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treatment under the cloak of non-disclosure. Doubtless, this is a reflection of the 
concern among the diseased that they may be discriminated against, should their 
disease status become public. Social stigma aside, the investigator discovered that 
many patients voluntarily isolated themselves within the house to prevent the risk of 
contagion (even where they had not disclosed their disease status to other family 
members). This only serves to underline the fear of the disease as well as public 
retribution. 
Of the 23 child contacts, only 7(30.4%) received IPT. In addition, 2(8.8%) of the child 
contacts received ATT. These figures are higher than the 19% reported by another 
study conducted in Tamil Nadu.16    
Among the respondents, awareness of the need to screen household contacts is 77%.  
Similarly, the awareness that household contacts need to be screened is significantly 
influenced by the following factors:  
i) The presence of a symptomatic or child contact (OR 0.095(0.009-0.983) 
(p=0.048). 
ii) Being employed (OR 0.263(0.075-0.928) (p=0.038), and 
iii) Being educated (OR 0.162(0.036-0.725) (p=0.017) 
Those who are educated/ employed or have symptomatic or child contacts are less likely 
to be aware of the need to screen their contacts. Thus, while those who are educated 
are more likely to be advised to undertake contact screening, they are less likely to be 
70 
 
aware of the need to do so. It is possible that this is a reflection of the (extra ) efforts 
most health care workers tend to take while explaining things to uneducated patients. 
Since they are considered to be unable to grasp concepts easily, they probably receive 
more attention from the system as a whole, either through more frequent health 
education interventions, or the mere process of simplifying concepts to the very basics 
to facilitate comprehension. Those who are educated on the other hand, are likely to 
be told just once, and that too using a lot of jargon. Consequently, it is the educated 
who are less aware. While this explanation is plausible, definite inferences cannot be 
deduced using the limited data collected as part of the study.  
Of all those who were aware of the need to screen contacts, only 45(69%) knew how 
contact screening could be performed. Though this was not statistically significant, it 
has significant implications for the programme. Awareness is linked to attitude and 
behaviour.61 Only when patients are aware of the details of the disease, how it is 
transmitted,etc., will they comprehend the risks of non-compliance with treatment as 
well as contact screening.  
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8. LIMITATIONS 
The main limitation of the study was maintaining confidentiality about the illness 
while verifying addresses. The investigator had to struggle to explain the purpose of 
the visit to respondents, especially when other relatives and acquaintances (who were 
unaware that the patient had received treatment for TB) were also present. In those 
situations the investigator had to request a private audience with the patient, either in a 
nearby place, or at a location of the patient’s choice. 
Conversely, there were situations where the patient’s illness was already a topic of 
discussion among the local people. These were patients who had been very irregular 
on treatment, or were very sick, or both. They had received numerous visits from 
other health care workers in the past, some of whom were (apparently) quite 
indiscreet. It was assumed that the investigator had visited the patient due to the 
illness, and on occasion, the same was enquired of the investigator to confirm their 
“suspicions”. The investigator always gave deliberately vague responses to such 
queries so that the true purpose of the visit was not known. However, the success of 
this strategy could not be ascertained. 
The other limitation was in terms of the ability of the respondents to comprehend the 
questions pertaining to the screening of contacts. This problem was acute in situations 
where the patient did not have any contacts. The response to the question, “Do 
household contacts need to be screened?” was invariably met with irritation that the 
question wasn’t relevant to the respondent since (s)he did not have any contacts 
whatsoever. 
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The responses to the question, “How can household contacts be screened?” were also 
difficult to come by. The typical initial response was that it depended upon the 
Doctor. Responses were easier to come by when the respondents were well educated. 
Since the required sample (N=84) was reached, the remaining patients were not 
contacted. 
Lastly, the including the service providers in the study to ascertain their knowledge, 
attitudes and practices also would have provided the complete picture of the current 
situation. This could not be done due to resource constraints.  
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9. CONCLUSIONS 
The major conclusions of this study are: 
1. Among the respondents, only 31% were advised to screen their household 
contacts for the presence of TB. 
2. Being advised to screen contacts is significantly associated with the  
education of the patient (p=0.026).The  presence of a symptomatic or 
child contact (p=0.002) is likely to result in the patient not being advised 
to undertake screening.   
3. Only 23% of all respondents undertook screening of their household 
contacts for TB. 
4. Screening of contacts is significantly associated with the presence of a 
symptomatic or child contact (p=<0.001). Those with a symptomatic or 
child contact are less likely to undertake the screening of contacts.  
5. Of the 23 child contacts, only 7(30.4%) were initiated on Isoniazid 
Prophylaxis Treatment (IPT). Two (8.8%) others were started on ATT 
following screening. 
6. 77% of the respondents were aware of the need to screen their household 
contacts.  
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7. Awareness regarding the need to screen contacts is significantly 
associated with the presence of a symptomatic or child contact (p=0.048); 
being educated (p=0.017); and being employed (p=0.038). The presence 
of these factors is likely to result in the patient not being aware of the need 
to screen contacts. 
8. Of all those who said that household contacts need to be screened, only 
69% knew how this could be done. 
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10. RECOMMENDATIONS 
Larger studies are needed to confirm the findings of this study. 
 It is also recommended that studies assessing the knowledge, attitude and practice of 
health care workers regarding management of contacts of TB patients be carried out.  
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APPENDIX 2 
INDIVIDUAL CROSS-TABULATION ANALYSIS TABLES 
SECTION 1. CROSS-TABULATION ANALYSIS BY FACTORS CONTRIBUTING 
TO A PATIENT BEING ADVISED TO SCREEN CONTACTS 
Table 1.     Sex of the patient by advise to undertake contact screening (N=84)  
 ADVISED NOT 
ADVISED 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
MALE 19(31.1%) 42(68.9%)  
1.023(0.497-2.106) 
 
0.950 FEMALE 7(30.4%) 16(69.6%) 
Table 2. Age of the patient by advise to undertake contact screening (N=84) 
 ADVISED NOT ADVISED ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
18-45 YEARS 11(29.7%) 26(70.3%)  
0.932(0.487-1.781) 
 
0.830 >45 YEARS 15(31.9%) 32(68.1%) 
Table 3. Education of the patient by advise to undertake contact screening (N=84) 
 ADVISED NOT ADVISED ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
EDUCATED 18(26.1%) 51(73.9%)  
0.489(0.264-0.907) 
 
0.039 UNEDUCATED 8(53.3%) 7(46.7%) 
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Table 4. Employment status of the patient by advise to undertake contact screening (N=84) 
 ADVISED NOT ADVISED ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
EMPLOYED 15(30.6%) 34(69.4%)  
0.974(0.511-1.858) 
 
0.936 UNEMPLOYED 11(31.4%) 24(68.6%) 
 
Table 5. Marital status of the patient by advise to undertake contact screening (N=84) 
 ADVISED NOT ADVISED ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
MARRIED 18(31.6%) 39(68.4%)  
1.066(0.532-2.137) 
 
0.857 OTHERS 8(29.6%) 19(70.4%) 
Table 6. Distance to PHI by advise to undertake contact screening (N=84) 
 ADVISED NOT ADVISED ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
≤ 5Km 13(23.6%) 42(76.4%)  
0.527(0.283-0.984) 
 
0.046 >5 Km 13(44.8%) 16(55.2%) 
Table 7. Presence of any symptomatic or child contact by advise to undertake contact 
screening (N=84) 
 ADVISED NOT ADVISED ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
SYMPTOMATIC 
CONTACTS 
PRESENT 
 
12(60.0%) 
 
8(40.0%) 
 
 
 
2.743(1.528-4.924) 
 
 
 
0.001 SYMPTOMATIC 
CONTACTS 
NOT 
PRESENT 
 
14(21.9%) 
 
50(78.1%) 
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Table 8. Presence of any child contact by advise to undertake contact screening (N=84) 
 ADVISED NOT ADVISED ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
CHILD 
CONTACT 
PRESENT 
 
11(57.9%) 
 
8(42.1%) 
 
 
2.509(1.395-4.510) 
 
 
0.004 
NO CHILD 
CONTACT 
15(23.1%) 50(76.9%) 
Table 9. Family history of tuberculosis by advise to undertake contact screening (N=84) 
 ADVISED NOT ADVISED ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
FAMILY 
HISTORY 
PRESENT 
 
8(29.6%) 
 
19(70.4%) 
 
 
0.938(0.468-1.881) 
 
 
0.857 
NO FAMILY 
HISTORY 
18(31.6%) 39(68.4%) 
Table 10. Any Category II/ IV by advise to undertake contact screening (N=84) 
 ADVISED NOT ADVISED ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
ANY CAT II/ 
CAT IV 
12(40.0%) 18(60.0%)  
1.543(0.823-2.893) 
 
0.181 
CAT I 
 
14(25.9%) 40(74.1%) 
Table 11. Any ever treated Relapse/Default/Failure by advise to undertake contact screening 
(N=84) 
 ADVISED NOT ADVISED ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
ANY EVER 
TREATED 
RELAPSE/ 
DEFAULT/ 
FAILURE 
 
 
8(38.1%) 
 
 
13(61.9%) 
 
 
 
1.333(0.682-2.607) 
 
 
 
0.414 
OTHERS 
 
18(28.6%) 45(71.4%) 
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Table 12. Any Default by advise to undertake contact screening (N=84) 
 ADVISED NOT ADVISED ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
ANY 
DEFAULT 
7(33.3) 14(66.7%)  
1.105(0.542-2.253) 
 
0.785 
OTHERS 19(30.2%) 44(69.8%) 
SECTION 2. CROSS-TABULATION  ANALYSIS BY FACTORS INFLUENCING 
PATIENTS TO UNDERTAKE CONTACT SCREENING 
Table 13. Sex by contact screening (N=84) 
 SCREENING 
DONE 
SCREENING 
NOT DONE 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
MALE 15(24.5%) 46(75.4%)  
1.414(0.524-3.817) 
 
0.482 FEMALE 4(17.4%) 19(82.6%) 
Table 14. Age of the patient by contact screening (N=84) 
 SCREENING 
DONE 
SCREENING 
NOT DONE 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
18-45 YEARS 8(21.6%) 29(78.4%)  
0.924(0.414-2.061) 
 
0.846 >45 YEARS 11(23.4%) 36(76.6%) 
Table 15. Education of the patient by contact screening (N=84) 
 SCREENING 
DONE 
SCREENING 
NOT DONE 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
EDUCATED 16(23.2%) 53(76.8%)  
1.159(0.386-3.481) 
 
0.789 UNEDUCATED 3(20.0%) 12(80.0%) 
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Table 16. Employment status of the patient by contact screening (N=84) 
 SCREENING 
DONE 
SCREENING 
NOT DONE 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
EMPLOYED 8(16.3%) 41(83.7%)  
0.519(0.233-1.157) 
 
0.103 UNEMPLOYED 11(31.4%) 24(68.6%) 
Table 17. Marital status of the patient by contact screening (N=84) 
 SCREENING 
DONE 
SCREENING 
NOT DONE 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
MARRIED 15(26.3%) 42(73.7%)  
1.776(0.651-4.845) 
 
0.239 OTHERS 4(14.8%) 23(85.2%) 
Table 18. Distance to PHI by contact screening (N=84) 
 SCREENING 
DONE 
SCREENING 
NOT DONE 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE  
(p VALUE) 
≤ 5Km 14(25.5%) 41(74.5%)  
1.476(0.590-3.692) 
 
0.392 >5 Km 5(17.2%) 24(82.8%) 
Table 19. Presence of any symptomatic or child contact by contact screening (N=84) 
 SCREENING 
DONE 
SCREENING 
NOT DONE 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
SYMPTOMATIC 
CONTACTS 
PRESENT 
 
13(65.0%) 
 
7(35.0%) 
 
 
 
6.933(3.033-15.850) 
 
 
 
<0.001 SYMPTOMATIC 
CONTACTS 
NOT 
PRESENT 
 
6(9.4%) 
 
58(90.6%) 
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Table 20. Presence of any child contact by contact screening (N=84) 
 SCREENING 
DONE 
SCREENING 
NOT DONE 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
CHILD 
CONTACT 
PRESENT 
 
12(63.2%) 
 
7(36.8%) 
 
 
5.865(2.690-12.787) 
 
 
<0.001 NO CHILD 
CONTACT 
7(10.8%) 58(89.2%) 
Table 21. Family history of tuberculosis by contact screening (N=84) 
 SCREENING 
DONE 
SCREENING 
NOT DONE 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
FAMILY 
HISTORY 
PRESENT 
 
8(29.6%) 
 
19(70.4%) 
 
 
1.535(0.699-3.374) 
 
 
0.291 NO FAMILY 
HISTORY 
11(19.3%) 46(80.7%) 
Table 22. Any Category II/ IV by contact screening (N=84) 
 SCREENING 
DONE 
SCREENING 
NOT DONE 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
ANY CAT II/ 
CAT IV 
11(36.7%) 19(63.3%)  
2.475(1.119-5.475) 
 
0.022 
CAT I 8(14.8%) 46(85.2%) 
 
 
 
95 
 
Table 23. Any ever treated Relapse/Default/Failure by contact screening (N=84) 
 SCREENING 
DONE 
SCREENING 
NOT DONE 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
ANY EVER 
TREATED 
RELAPSE/ 
DEFAULT/ 
FAILURE 
 
 
9(42.9%) 
 
 
12(57.1%) 
 
 
 
2.700(1.272-5.733) 
 
 
 
0.010 
OTHERS 10(15.9%) 53(84.1%) 
Table 24. Any Default by contact screening (N=84) 
 SCREENING 
DONE 
SCREENING 
NOT DONE 
ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
ANY 
DEFAULT 
4(19.0%) 17(81.0%)  
0.800(0.298-2.145) 
 
0.651 
OTHERS 15(23.8%) 48(76.2%) 
 
SECTION 3. CROSS-TABULATION ANALYSIS BY FACTORS POTENTIALLY 
INFLUENCING PATIENTS’ AWARENESS THAT CONTACTS NEED TO BE 
SCREENED 
Table 25. Sex by awareness that contacts need to be screened (N=84) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
MALE 49(80.3%) 12(19.7%)  
1.155(0.858-1.555) 
 
0.239 FEMALE 16(69.6%) 7(30.4%) 
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Table 26. Age by awareness that contacts need to be screened (N=84) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
18-45 YEARS 33(89.2%) 4(10.8%)  
1.310(1.045-1.641) 
 
0.022 >45 YEARS 32(68.1%) 15(31.9%) 
Table 27. Education by awareness that contacts need to be screen (N=84) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
EDUCATED 59(85.5%) 10(14.5%)  
2.138(1.142-4.003) 
 
<0.001 UNEDUCATED 6(40.0%) 9(60.0%) 
Table 28. Employment status by awareness that contacts need to be screened (N=84) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
EMPLOYED 43(87.8%) 6(12.2%)  
1.396(1.060-1.839) 
 
0.007 UNEMPLOYED 22(62.9%) 13(37.1%) 
Table 29. Marital status by awareness that contacts need to be screened (N=84) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
MARRIED 44(77.2%) 13(22.8%)  
0.992(0.776-1.269) 
 
0.952 OTHERS 21(77.8%) 6(22.2%) 
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Table 30. Distance to PHI by awareness that contacts need to be screened (N=84) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
≤ 5Km 42(76.4%) 13(23.6%)  
0.963(0.760-1.220) 
 
0.759 >5 Km 23(79.3%) 6(20.7%) 
Table 31. Presence of symptomatic or child contacts by awareness that contacts need to 
be screened (N=84) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
SYMPTOMATIC 
CONTACTS 
PRESENT 
 
19(95.0%) 
 
1(5.0%) 
 
 
 
1.322(1.100-1.588) 
 
 
 
0.031 SYMPTOMATIC 
CONTACTS 
NOT 
PRESENT 
 
46(71.9%) 
 
18(28.1%) 
Table 32. Presence of child contacts by awareness that contacts need to be screened 
(N=84) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
CHILD 
CONTACT 
PRESENT 
 
18(94.7%) 
 
1(5.3%) 
 
 
1.310(1.090-1.575) 
 
 
0.040 NO CHILD 
CONTACT 
47(72.3%) 18(27.7%) 
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Table 33. Family history of TB by awareness that contacts need to be screened (N=84) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
FAMILY 
HISTORY 
PRESENT 
 
25(92.6%) 
 
2(7.4%) 
 
 
1.319(1.080-1.612) 
 
 
0.022 NO FAMILY 
HISTORY 
40(70.2%) 17(29.8%) 
Table 34. Any Category II/ Category IV by awareness that contacts need to be screened 
(N=84) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
ANY CAT II/ 
CAT IV 
24(80.0%) 6(20.0%)  
1.054(0.834-1.331) 
 
0.669 
CAT I 41(75.9%) 13(24.1%) 
Table 35. Any ever treated Relapse/Default/Failure by awareness that contacts need to be 
screened (N=84) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
ANY EVER 
TREATED 
RELAPSE/ 
FAILURE/ 
DEFAULT 
 
 
17(81.0%) 
 
 
4(19.0%) 
 
 
 
1.063(0.828-1.363) 
 
 
 
0.651 
OTHERS 48(76.2%) 15(23.8%) 
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Table 36. Any Default by awareness that contacts need to be screened (N=84) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
ANY 
DEFAULT 
14(66.7%) 7(33.3%)  
0.824(0.595-1.140) 
 
0.175 
OTHERS 51(81.0%) 12(19.0%) 
SECTION 4. CROSS-TABULATION ANALYSIS BY FACTORS POTENTIALLY 
INFLUENCING PATIENTS’ AWARENESS REGARDING HOW TO SCREEN 
CONTACTS  
Table 37. Sex by awareness on how contacts can be screened (N= 65) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
MALE 31(63.3%) 18(36.7%)  
0.723(0.545-0.959) 
 
0.068 FEMALE 14(87.5%) 2(12.5%) 
Table 38. Age by awareness on how contacts can be screened (N= 65) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
18-45 YEARS 24(72.7%) 9(27.3%)  
1.108(0.800-1.536) 
 
0.535 >45 YEARS 21(65.6%) 11(34.4%) 
 
 
 
100 
 
 
Table 39. Education by awareness on how contacts can be screened (N= 65) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
EDUCATED 41(69.5%) 18(30.5%)  
1.042(0.578-1.881) 
 
0.886 UNEDUCATED 4(66.7%) 2(33.3%) 
Table 40. Employment status by awareness on how contacts can be screened (N= 65) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
EMPLOYED 30(69.8%) 13(30.2%)  
1.023(0.723-1.447) 
 
0.896 UNEMPLOYED 15(68.2%) 7(31.8%) 
Table 41. Marital status by awareness on how contacts can be screened (N= 65) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
MARRIED 29(65.9%) 15(34.1%)  
0.865(0.628-1.191) 
 
0.401 OTHERS 16(76.2%) 5(23.8%) 
Table 42. Distance to PHI by awareness on how contacts can be screened (N= 65) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
≤ 5Km 31(73.8%) 11(26.2%)  
1.213(0.834-1.762) 
 
0.280 >5 Km 14(60.9%) 9(39.1%) 
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Table 43. Presence of symptomatic or child contacts by awareness on how contacts can 
be screened (N= 65) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
SYMPTOMATIC 
CONTACTS 
PRESENT 
 
13(68.4%) 
 
6(31.6%) 
 
 
 
0.984(0.686-1.410) 
 
 
 
0.928 SYMPTOMATIC 
CONTACTS 
NOT 
PRESENT 
 
32(69.6%) 
 
14(30.4%) 
Table 44. Presence of child contacts by awareness on how contacts can be screened     
(N= 65) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
CHILD 
CONTACT 
PRESENT 
 
12(66.7%) 
 
6(33.3%) 
 
 
0.949(0.652-1.383) 
 
 
0.782 NO CHILD 
CONTACT 
33(70.2%) 14(29.8%) 
Table 45. Family history of TB by awareness on how contacts can be screened (N= 65) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
FAMILY 
HISTORY 
PRESENT 
 
19(76.0%) 
 
6(24.0%) 
 
 
1.169(0.852-1.605) 
 
 
0.350 NO FAMILY 
HISTORY 
26(65.0%) 14(35.0%) 
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Table 46. Any Category II/ Category IV by awareness on how contacts can be screened 
(N= 65) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
ANY CAT II/ 
CAT IV 
17(70.8%) 7(29.2%)  
1.037(0.745-1.444) 
 
0.830 
CAT I 28(68.3%) 13(31.7%) 
Table 47. Any ever treated Relapse/Default/Failure by awareness on how contacts can be 
screened (N= 65) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
ANY EVER 
TREATED 
RELAPSE/ 
DEFAULT/ 
FAILURE 
 
 
12(70.6%) 
 
 
5(29.4%) 
 
 
 
1.027(0.715-1.474) 
 
 
 
0.888 
OTHERS 33(68.8%) 15(31.3%) 
Table 48. Any Default by awareness on how contacts can be screened (N= 65) 
 AWARE NOT AWARE ODDS RATIO 
(95% CI) 
SIGNIFICANCE 
(p VALUE) 
ANY 
DEFAULT 
8(57.1%) 6(42.9%)  
0.788(0.485-1.278) 
 
0.269 
OTHERS 37(72.5%) 14(27.5%) 
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APPENDIX 3. 
INFORMATION SHEET (ENGLISH) 
                                                INFORMATION SHEET                                                 
Name of the study: A study on the Household Contacts Of Sputum Positive Pulmonary 
Tuberculosis in a rural area in South India. 
 
You are invited to participate in the above mentioned study. This is a research project 
which aims to find out details about the screening of household contacts of sputum 
positive pulmonary tuberculosis patients in the rural population in Kaniyambadi 
Tuberculosis Unit area. 
 
The investigator will come and perform the following procedures: 
Ask you a few questions 
Give health education regarding the importance of screening of household contacts of 
sputum positive pulmonary Tuberculosis patients. 
Based on your responses, the investigator may advise the following free tests for a 
household contact: i) Sputum examination 
                               ii) An injection in the left forearm 
                               iii) Chest X-Ray 
 
There are no major risks associated with these procedures. The injection in the left 
forearm may be painful. 
 
By participating in this study (if warranted) your household contact(s) get a free chest X-
Ray, sputum examination and Mantoux test, which would help detect Tuberculosis. 
The results will help the investigators give the household contact(s) treatment if the 
household contact(s) have Tuberculosis. If any serious illness is detected, then your 
household contact(s) will be appropriately referred to CHAD Hospital, Bagayam, 
CMC Hospital, Vellore, or Tuberculosis Research Centre, Tambaram, Chennai. 
 
The information obtained from you may be used for publication in scientific journals. All 
information collected from you will be kept confidential. No personal details will be 
revealed to anyone. Participation in this study is entirely voluntary. You may 
withdraw from the study or refuse to participate at any point of time. 
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APPENDIX  4 
CONSENT FORM (ENGLISH) 
INFORMED CONSENT 
Study Title: A study on the Household contacts of Sputum Positive Tuberculosis patients 
                  in a rural area in South India. 
 
Subject’s Initials: _________ Subject’s Name: ________ 
Date of Birth / Age:_______ 
Please initial box  
(Subject) 
(i) I confirm that I have read and understood the information sheet dated _________ for 
the above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care or legal 
rights being affected. [ ] 
 (iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor’s 
behalf, the Ethics Committee and the regulatory authorities will not need my 
permission to look at my child/ward/ spouse/ other household contacts’ health records 
both in respect of the current study and any further research that may be conducted in 
relation to it, even if I withdraw from the trial. I agree to this access. However, I 
understand that my child/ward/ spouse/ other household contacts’ identity will not be 
revealed in any information released to third parties or published. [ ] 
(iv) I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
 
Signature (or Thumb impression) of the Patient/Parent/Spouse/Legally Acceptable 
Representative:_____________ 
Date: _____/_____/______ 
Signatory’s Name: _________________________________ 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator’s Name: _________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: ______________________________ 
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APPENDIX 5 
INFORMATION SHEET (TAMIL) 
jftš got« 
MuhŒ¢Áæ‹ jiy¥ò 
  bj‹ ÏªÂahé‹ »uhk¤Âš cŸs Eiupuš fhr nehahëfë‹ Å£oš bjhl®òŸs eg®fël« 
el¤j¥gL« MŒÎ. 
nk‰T¿a MuhŒ¢Áæš g§nf‰f Ú§fŸ miH¡fg»Ö®fŸ. Eiupuš fhr 
nehahëfSl‹ bjhl®ò cŸst®fS¡F brŒj gçnrhjidfŸ g‰¿ bjçªJ bfhŸtJ Ïªj 
MuhŒ¢Áæ‹ neh¡f«. 
MuhŒ¢Á¡fhf bjçªJbfhŸs¥g£l gFÂ fhrnehŒ Á»¢ir braš gL¤J« 
fâa«ghot£lhu«. 
MuhŒ¢Áahs® Å£o‰F tªJ Ñœf©l Kiwfis filÃo¥gh®. 
 c§fël« Áy nfŸéfŸ nf£gh®. 
 rëæš fhrnehŒ »Uä cŸst®fël« bjhl®ò cŸst®fS¡F gçnrhjid brŒa nt©oaÂ‹ 
mtÁa¤ij¥ g‰¿ Rfhjhu fšé më¥gh®. 
mjid mo¥gilahf bfh©L  MuhŒ¢Áahs® Ñœf©l gçnrhjidfŸ brŒtj‰F 
m¿Îiw TWth®. 
rë gçnrhjid 
  ÏlJ ifæš CÁ 
  kh®ò v¡°nu 
  
Ïªj gçnrhjidædhš vªjéjkhd ghÂ¥ò« Ïšiy. ifæš nghL« CÁ xU ntis tè¡fyh«. 
 Ïªj MuhŒ¢Áæš g§bfL¥gÂ‹ _ykhf njit ÏUªjhš Ïytrkhf kh®ò v¡°nu , rë gçnrhjid fhr 
nehŒ ÏU¡»wjh v‹gij f©l¿Í« nrhjid CÁ nghl¥gL«. mj‹ _ykhf fhr nehŒ 
f©l¿a¥g£lhš mt®fS¡F itÂa« brŒa MuhŒ¢Áahs®fS¡F cjÎ«. VjhtJ ga¥gL¥ goahd 
éahÂ f©l¿a¥g£lhš bjhl®ò cŸst®fŸ rh£ kU¤Jtkid ghfha«, »¿¤Jt kU¤Jtkid ntÿ® 
mšyJ fhr nehŒ MuhŒ¢Á ika« jh«gu« br‹id¡F bršYkhW gçªJiu brŒa¥gLth®fŸ. 
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 c§fël« ÏUªJ bgw¥gL« jftšfŸ éŠrhd ò¤jf¤Âš btëæl¥glyh«. c§fël« ÏUªJ bgw¥gL« 
jftšfŸ g¤Âukhf e«Ã¡ifahf ghJfh¡f¥gL«. jå¥g£l jftšfŸ ahçlK« Twkh£nlh«.  Ïªj 
MuhŒ¢Áæš Ú§fŸ  jhdhf K‹tªJ g§nf‰fyh«. Ïªj MuhŒ¢ÁæYUªJ Ú§fŸ c§fŸ 
éU¥g¥go éy» bfhŸsyh« mšyJ v¥nghJ nt©LkhdhY« ãW¤Â¡ bfhŸsyh«. 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 6 
CONSENT FORM (TAMIL) 
x¥òjš got« 
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 bj‹ ÏªÂahé‹ »uhk¤Âš cŸs Eiupuš fhr nehahëfë‹ Å£oš bjhl®òŸs eg®fël« 
el¤j¥gL« MŒÎ. 
 
MuhŒ¢Áæš g§bfL¥gtç‹  KjbyG¤J:______________________ 
MuhŒ¢Áæš g§bfL¥gtç‹  bga® : ______________________ 
Ãwªj njÂ  / taJ    : ____/_____/______   _____ 
  
1 Ïªj MuhŒ¢Áia g‰¿ eh‹ go¤J, òçªJ bfh©nl‹ v‹gij cWÂ brŒ»nw‹. nkY« 
nfŸéfŸ nf£gj‰F vd¡F thŒ¥gë¡f¥g£lJ. 
2 v‹ FHªij / kidé / fzt® / k‰wf®fŸ Ïªj MuhŒ¢Áæš Rakhf g§bfL¡fyh« vd 
bjçªJbfh©nl‹. v¥nghJ nt©khdhY« v‹Dila kU¤Jt njitfŸ k‰W« r£l cçikfŸ 
ghÂ¡fht©z«, fhuz§fŸ vJÎ« Twhkš Ïªj MuhŒ¢Áæš ÏUªJ éy»bfhŸs vd¡F 
cçik cŸsJ v‹gij bjçªJŸns‹. 
3 Ïªj MuhŒ¢Áæ‹ bghW¥ghs®, cl‹ ntiy brŒgt®, XG¡féa‰  bra‰FG k‰W« 
f£Lgh£L thça« M»nah®, el¤Â¡  bfh©oU¡F« MuhŒ¢Á nkY« el¡f ÏU¡F« 
MuhŒ¢Áæš ÏUªJ eh‹ éy»dhY« v‹ FHªij / kidé / fzt® / v‹Dl‹ tÁ¡F« 
cwéd®fë‹ gÂntLfis gh®¡f v‹Dila mDkÂ njitæšiy v‹gij e‹F m¿ªÂU¡»nw‹. 
nkY« v‹ FHªij / kidé / fzt® / v‹Dl‹ tÁ¡F« cwéd®fis g‰¿a jftš mšyJ  
milahs¤ij és«gugL¤Jnth mšyJ _‹whtJ egU¡F bjça¥gL¤j kh£lh® v‹gij 
m¿ªÂU¡»nw‹. 
4 Ïªj MuhŒ¢Áæš ÏUªJ bgw¥gL« jftšfS« , gçnrhjid KoÎfS« éŠrhd rh®ªj 
fhça¤Â‰F ga‹gL¤jyh« v‹W mDkÂ më¡»nw‹, 
5 Ïªj MuhŒ¢Áæš v‹ FHªij / kidé / fzt®  k‰W« FL«g m§f¤Âd® g§nf‰gÂš 
vd¡F r«kj«. 
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6 eh‹ nk‰f©l MuhŒ¢Áæš g§nf‰f r«kÂ¡»nw‹. 
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nehahë / bg‰nwh® / fzt® / kidé / r£l¥go ãaä¡f¥g£l  
ÃuÂãÂæ‹ ifbah¥g« / bgUéuš ifnuif   : 
 
njÂ : 
 
ifbaG¤J ÏLgtç‹ bga® : ___________________________ njÂ:_________
MuhŒ¢Áahsç‹ 
ifbah¥g« 
: ___________________________ njÂ:_________
MuhŒ¢Áahsç‹ bga® : ___________________________ njÂ:_________
rh£Áahsç‹ ifbah¥g« : ___________________________ njÂ:_________
rh£Áahsç‹ bga®  : ___________________________ njÂ:_________
 
                                  STUDY ON THE HOUSEHOLD CONTACTS OF SPUTUM POSITIVE TUBERCULOSIS PATIENTS 
 
1. DATE OF INTERVIEW                                                                   2. SERIAL NO.                                    3. ID NO.                                                            
4. VILLAGE NAME …………………………………………………….                                                                                                                                                     
5. NAME OF RESPONDENT ………………………………………         6. AGE                             7. EDUCATION                               8. OCCUPATION………………………. 
9. PLACE OF WORK ……………………  10. MARITAL STATUS i) SINGLE  ii) MARRIED iii) WIDOW/WIDOWER  Iv) DIVORCED/SEPARATED                          
11. SMOKER                 i)YES        ii)NO        iii)EX‐SMOKER         iv)PASSIVE SMOKER                                             ALCOHOL CONSUMPTION  i)YES  ii)NO 
FOR i) AND iii)Æ   a.  BEEDI/ CIGARETTE   b. PACK YEARS                          FOR iv) NO. OF YEARS                             DURATION                                                                  
12. CONSUMES TOBACCO         i)YES         ii) NO                                           13. FAMILY HISTORY OF TUBERCULOSIS   i) YES      ii) NO                                  
                                                                                                        SECTION 1 (PATIENT)                                                                                                                   
A. DETAILS OF ILLNESS                                                                                                                                                                                                           
1. SYMPTOMS PRIOR TO DIAGNOSIS                                                                                                                                                                              
i) COUGH ≥ 2 WEEKS   ii)FEVER ≥ 2 WEEKS  iii)HEMOPTYSIS  iv)DYSPNEA ≥ 2 WEEKS V)LOSS OF WEIGHT Vi) OTHERS (SPECIFY) 
2. DURATION OF SYMPTOMS ………………………         3. DATE OF DIAGNOSIS                                                                                                    
              4.    DATE OF STARTING TREATMENT                                                                  5.  DATE OF TREATMENT COMPLETION                                                                                               
              6.   TREATMENT OBTAINED FROM (DOTS CENTER’S NAME) ……………………………. 7. DURATION OF TREATMENT (IN MONTHS)    
              8.   TREATMENT CARD   i)AVAILABLE   ii) LOST  iii) NOT GIVEN                                  10.   ADVISED CONTACT SCREENING?  I)YES   ii)NO  iii)YES,BUT LATER 
9. ANY SYMPTOMATIC HOUSEHOLD CONTACTS DURING ILLNESS?  i) YES ii) NO                 11. CONTACT SCREENING DONE? I)YES  ii)NO 
APPENDIX 7. 
STUDY QUESTIONNAIRE 
       IF YES, WHETHER SCREENED i) YES ii) NO                         METHOD OF SCREENING…………………………………………………………………  
 12.   ANY CHILD CONTACTS?  I)YES  ii) NO     13. BCG SCAR PRESENT?  I)YES   ii)NO 
14. TOTAL NUMBER OF CHILD CONTACTS……………..    15. INH PROPHYLAXIS GIVEN? I)YES  ii)NO  16. IF YES, DURATION……………………………………                                                
B. AWARENESS REGARDING SCREENING OF HOUSEHOLD CONTACTS                                                                                                                                        
1. DO HOUSEHOLD CONTACTS NEED TO BE SCREENED? 
i) YES                            
a. WHY? …………………………………………………………………………………………………………………………………………………………………………         
b. HOW CAN THEY BE SCREENED? ………………………………………………………………………………………………………………………………...   
ii) NO                                                                                                                                                                                                                       
                                                                                             SECTION II (HOUSEHOLD CONTACTS)                                                                                        
S. NO.  NAME  AGE  SEX  EDU. 
QUAL. 
MARITAL 
STATUS 
REL. TO 
PATIENT 
DURATION OF 
CONTACT  
           SCREENED FOR TB? 
NO                                YES 
                       HOW?              RESULT 
          CURRENTLY SYMPTOMATIC?           
 NO                                      YES                           
                  SYMPTOMS          DURATION                 
         
                   
         
                   
                   
                   
                   
 
